failure and a crucial determinant of myocardial heterogeneity, increasing diastolic stiffness, and the propensity for reentry arrhythmias. In addition, systolic dysfunction is facilitated by slowing of the calcium transient and the downregulation of the entire adrenergic system. Modifications of intracellular calcium movements are the main determinants of the triggered activity and automaticity that cause arrhythmias and alterations in relaxation.
I. DEFINITION: LIMITATIONS
need a specific approach and are excluded from the present review. From an epidemiological point of view, MI and arterial hypertension are both more frequent in aged ''Remodeling'' qualifies changes that result in the rearpersons. In addition, the structural modifications that are rangement of normally existing structures. Although reobserved during senescence in healthy individuals has modeling does not necessarily define a pathological condiseveral points in common with the mechanically overtion, myocardial remodeling is usually restricted to loaded heart (32). diseased conditions. The above definition eliminates gesCardiac remodeling is triggered by mechanical tational and developmental aspects and also the so-called stretch; nevertheless, there are also several different facphysiological cardiac hypertrophy that follows intensive tors including ischemia, hormones, and vasoactive pepexercising.
tides, which can modify the effects of the mechanical Remodeling concerns the two components of the carfactor. The most common clinical situation during which diovascular system. The structure of both the myocarremodeling is known to occur is a rather complex mixture dium and the vessels, including the coronary vessels, is of ischemia, stretch due to pressure overload, stress due indeed able to change under the influence of external a myocardial scar, and increased plasma levels of horfactors, such as ischemia and mechanical overload. This mones or vasoactive peptides. An additional factor has to review is focused on acquired cardiac remodeling (CR) be listed, namely, the unknown signal that provides to the of the left myocardium. Remodeling of coronary arteries, heart the information concerning the amount of substance right ventricle, and atria [with the exception of the left that has been lost after MI and that is exactly recovered atrial changes that compensate for the deficit in left venby the compensatory hypertrophy; such a signal should tricular (LV) filling during CR], CR of genetic origin, the be similar to that occurring after uninephrectomy, unimechanisms of coronary restenosis, and remodeling of pneumonectomy, or partial hepatectomy. The mechathe large vessels under the influence of the atherosclerotic nisms by which cardiac growth occurs have already been process and arterial hypertension have been excluded. reviewed (85, 108, 234, 346, 515) , and because they could Although ''myocardial remodeling'' is now a widely themselves constitute a full review, they are not develused term, from a historical point of view it was initially oped in this review. used to describe the remodeling that occurs following
The permanent changes in molecular structure and myocardial infarction (MI). The meaning of the word was subsequently extended and used to qualify a variety of conditions including pure mechanical overload as well as The literature on the subject is extensive, and the Transgenic models of cardiac failure present review is focused on permanent modifications in Miscellaneous the left ventricle in relation to clinical dysfunction, in the their consequences in terms of cell physiology can be quently increase both preload and afterload, which results in an increased wall stress and a progressive thinning of divided into three principal mechanisms: the deleterious consequences of the general process of adaptation, in-the area. Simultaneously, in noninfarcted segments, elevation of the end-diastolic stress causes volume-overload hycluding cardiac hypertrophy, cell death, and fibrosis. The goal of this review is not only to review the extensive pertrophy that tends to normalize the wall stress according to Laplace's law. The extent and location of the infarction, literature concerning CR, but also to try to simplify a complex problem and to identify pathways for future re-therapy, or associated diseases may considerably modify remodeling (288) . search. A review on the same topic was published in 1982 (449); only a selection of the articles published before this When CR originates from a more general process such as arterial hypertension or valvular disease, the vendate have been quoted. tricular hypertrophy remains symmetric. Compensated cardiac hypertrophy (CCH) is concentric and is initially II. MORPHOLOGICAL AND CLINICAL BASIS characterized by a thick ventricular wall and septum, a normal internal volume and wall stress, and a high massto-volume ratio. Cardiac failure (CF) is progressive and A. Anatomic Basis is accompanied by a progressive enlargement of the ventricular cavity, and the mass-to-volume ratio returns to Cardiac remodeling is accompanied by an increase in LV mass and volume and a change in the shape of the normal values (444). ventricle (89, 90) . If the process is triggered by MI, the remodeling is asymmetric and is associated with infarct B. Cellular Alterations expansion.
Early ventricular remodeling following coronary occlusion is dominated by infarct expansion, which is an acute
The first demonstration that, in adults, cardiac myocytes hypertrophy and cardiac nonmuscular cells both dilation of the infarction area that cannot be explained by additional myocardial necrosis. Infarct expansion is caused hypertrophy and divide by mitosis was made using thymidine labeling in the laboratory of Rabinowitz and co-workby death and slippage of the myocytes; it usually predominates in the apical region of the left ventricle and dramati-ers (163, 319). This finding provided the basis for the general belief that postnatal growth of cardiocytes occurs cally alters ventricular volume and geometry. In rats, two days after a MI causing a loss of 63% of the myocytes, the through myocyte hypertrophy and that cardiac myocytes are terminally differentiated cells that are unable to reentransverse mid chamber diameter increases by 20% and the wall thickness decreases by 33%. Simultaneously, both the ter the cell cycle. In contrast, in the nonmuscle cells, which include both fibroblasts and endothelial cells, a total number of myocytes and capillary profile in the spared region of the LV free wall are reduced by 40%. The combina-hyperplastic component persists. Therefore, CR is a result of myocyte hypertrophy, hyperplasia, and hypertrophy of tion of these abnormalities indicates side-to-side myocyte slippage and accounts for the seven-to eightfold increase the nonmuscular cells and interstitial cell growth. Such a paradigm has however to be reevaluated, since CR is also in diastolic wall stress (338) .
Ventricular remodeling is the result of infarct expan-known to be associated with polyploidy (this has been well documented in the hypertrophied human heart; Refs. sion of akinetic-dyskinetic segments and volume-overload hypertrophy of noninfarcted segments. Catheterization and 2, 487), myocyte loss (see sect. V ), myocardial damage, and probably DNA repair. In addition, there is evidence ventriculography have demonstrated a volume enlargement, a lengthening of the ventricular perimeters, and an based on quantitative morphometry that, at least in human hearts (but it is nearly impossible to experimentally obincreased sphericity index both in systole and diastole that is accompanied by a blunting of the normal curvature of tained very bulky hearts, discussed in Ref. 187) , severe degrees of cardiac hypertrophy are accompanied by the apex. Later, what is usually called remodeling is characterized by additional enlargement and sphericity of the ven-cardiocyte proliferation (21, 258). There are also convincing data showing mitotic images in atrial and ventricular tricle, a decrease in stroke volume, and impaired diastolic filling (88, 148, 208, 288, 303, 352) . Based on these observa-cardiocytes during CF in humans and in the region adjacent to the necrotic area in both human hearts and in tions, the following model of ventricular remodeling after MI has been proposed: systolic impairment secondary to experimental models of MI (363, 384) . With the use of a morphometric approach, the mitotic index for cardiocyte the loss of contractile material results in an increased endsystolic volume, an increased cardiac size, and a secondary nuclei was rather high in the end-stage failing hearts compared with fetal hearts and was increased in the surviving augmentation of the diastolic filling pressure and distensibility. As the fibrosis increases, the distensibility decreases, tissue bordering the acute infarction. However, mitotic images observed during CF may not necessarily be indicaresulting in an increase in diastolic pressure and volume. Peripheral mechanisms including vasoconstriction subse-tive of cell division but could be a prerequisite for poly- trast, hypertrophy of cardiomyocytes is the result of the addition of new sarcomeres in parallel (152) . Such a hy- The effects of b-adrenergic blockade with bucindolol C. Clinical Setting and Treatment or carvedilol have also been examined in several placebocontrolled studies involving patients with CF and systolic Cardiac remodeling after MI is accompanied by a pro-dysfunction due to profound CR (123) . In all studies, LV gressive decline in ejection fraction over time, which sug-ejection fraction was consistently improved and ventricugests that CR, in this condition, would be better quanti-lar volume reduced. These effects appeared after 3-6 mo tated by measuring the LV ejection fraction (89, 148) . In of continuous therapy. Such a long-term treatment also hypertensive cardiopathy, there is a consistent and graded reverses CR by decreasing ventricular mass and volume. relation between blood pressure and the degree of con-There was also an increase in the sphericity index, which centric ventricular hypertrophy. Systolic and diastolic indicates that the ventricle recovers its ellipticity. dysfunction is progressive and is correlated with ventricular dilation.
III. PHENOTYPIC CHANGES IN MYOCYTES Several groups of clinical trials, using vasoactive drugs (89), b-adrenergic blocking agents (123) , converting enzyme inhibitors (CEI) (93, 430), or spironolactone (522) Because of the development in molecular and cellular biology, we have learned that, in response to mechanical have provided evidence that structural remodeling can be not only attenuated but even reversed and that the stimuli, both the myocardium and the vascular walls adapt to increased work loads by changes in gene expression. treatment of CR and its adverse effects can be targeted solely to the biological function of the myocardium.
However, nature has not provided infinite possibilities of new genetic programs. If one looks back during developRecent clinical trials have demonstrated the existence of two groups of vasoactive drugs: a 1 -blockers, such ment, such programs are usually available. In other words, to know, in a given animal species, what the genetic proas prazosin, which have no effect either on mortality rate or ejection fraction, and drugs such as hydralazine, isor-grams could be reexpressed in a given condition, the best strategy consists of exploring simultaneously the pattern bide dinitrate, and CEI that improve both the mortality rate and the ejection fraction. The first category of drugs of gene expression during development and in the pathological state. Such a strategy has been successfully applied has no effect on the progressive development of cardiac hypertrophy and dilation. In contrast, CEI significantly to mechanical overload and has led to the discovery that, during mechanical overload, only fetal isoforms were rereduces LV mass and volume (90) . Therefore, it is now possible to treat CR. In addition, such trials show that expressed in this condition (Table 2) . In skeletal muscle, hypertrophy due to intensive training or during muscle vasoactive peptides, like angiotensin II, have both a hemodynamic and a trophic effect.
regeneration is accompanied by the reexpression of sev-eral programs, including a fetal and an embryonic pro-concentration of the major plasma hormones and peptides. Despite their major importance, the latter have unfortugram because there are two programs that are expressed during development (442).
nately been rarely documented (142). Species specificity is another crucial methodological Nevertheless, in terms of genetic expression, there are differences between an embryo and patient suffering problem. The molecular determinants of ventricular adaptation and dysfunction are indeed species specific (451). In from arterial hypertension. In the first case, the changes in genetic expression are part of a sequential program. In contrast, an important conclusion of the previous thermodynamic study is that the fundamental physiological prothe second case, the endogenous program is associated with several other programs resulting from complex and cess of adaptation is the same, both in rabbits and humans (7) . The causes of cardiac hypertrophy may differ from one variable interactions between hormones, neurotransmitters, and plasma peptides. It is one of the goals of this animal species to another (for example, rats are resistant to atherosclerosis, dogs have a very particular valvular pareview to try to separate these two components from each other.
thology, and CF in humans in the affluent western countries is mostly secondary to hypertension and/or coronary insufficiency). Nevertheless, the most important cause of such A. Methodological Problems a species specificity is the fact that ventricular contraction is regulated by different processes that depend on both the type and the size of the animal. There are species such as Molecular or cellular studies on CR have raised several specific problems. 1) There are several experimental mod-rats or rabbits in which the adaptational process is caused by modifications of both the contractile machinery and the els of cardiac hypertrophy available, such as Goldblatt, aortic insufficiency, or abdominal aortic stenosis that need ex-calcium-regulating systems (129). In contrast, in humans (at least human ventricle) and guinea pigs, the contractile perienced hands to provide reproducible results and a reasonable (ú35%) degree of cardiac hypertrophy (187) . proteins are unlikely to be modified. The hypothesis is that in the latter group membrane proteins responsible for the Several outstanding biochemical or biological studies have indeed been based on experimental models that gave rise calcium movements play a major role in the adaptational process (306, 481) . to a cardiac hypertrophy of 20% or less (421) . Experimental models of CF are rare, expensive [i.e., aging spontaneously By comparing the results of mechanical studies performed on isolated fresh papillary muscles with those hypertensive rats (SHR); Ref. 47], and sometimes far away from the clinical reality, for example, the tachycardia-in-made on isolated skinned muscle fibers (fibers without any membrane structure) from pressure overloaded rats duced model which is not accompanied by hypertrophy (523).
2) The world-wide initiation of active cardiac trans-or guinea pigs (481), one can identify two different processes. When maximum shortening velocity (V max ) is deplantation programs has provided the possibility to obtain human tissue samples from both control and end-stage fail-termined on fresh muscles, it is altered in both animals.
In contrast, when muscular contraction is performed on ing hearts [New York Heart Association (NYHA) stage IV], including ischemic cardiopathy and idiopathic cardiomyop-skinned fibers, the shortening velocity is reduced only in pressure-overloaded rat hearts, but not in guinea pigs. athy, for physiological, molecular biological, and enzymatic use. Control samples can be obtained from donor hearts This indicates that in the absence of membrane structures, the fundamental process of adaptation is still present in which proved to be unsuitable for transplantation or from tissue discarded during surgical procedures. End-stage fail-the rat, whereas it has disappeared in guinea pigs. Calculations based on heat production have indicated that in the ing hearts always come from patients with end-stage disease, and it is therefore frequently difficult to decide rabbit ventricle the two mechanisms, namely, the sliding process and calcium movements, play roughly equivalent whether the differences reported between experimental animal models and human material are due to species differ-roles in the improvement of the economy ( Fig. 1) (6) .
Molecular investigations have confirmed such a view, and ences or reflect real different stages of the disease. 3) Technical and methodological problems are particularly frequent with the comparison of the ventricles and atria, it has been shown that there is, in addition, a tissue specificity. in this domain; extensive purification procedures may lead to selective extraction (see below a good example concernFIG. 1. Energy transduction in cardiac remodeling. Data are expressed as percent controls. CCH, compensated cardiac hypertrophy due to pulmonary artery stenosis; HF, heart failure due to dilated cardiomyopathy in humans. Forcetime integral is measured in isometric conditions. Shortening velocity is calculated in isotonic conditions. ** Significantly different from controls. [Data recalculated from Alpert et al. (7) and Hasenfuss et al. (183) .] is referred to as adaptive. Mechanical overload of a stri-Cardiac hypertrophy adapts the heart to the new working conditions by both multiplying the contractile units and ated muscle immediately reduces the instantaneous shortening velocity by simply bringing into play the mechanical reducing the wall stress according to Laplace's law.
Following the pioneer studies by Schreiber et al. properties of the myofiber. When the load is greater, the fiber contracts more slowly, and this results in an immedi-(406) performed on isolated working guinea pig hearts, a considerable amount of work using radioactive amino ate decrease in the economy (i.e., the number of ATP molecules burned per gram of tension) of the system, acid labeling was performed, and extensive reviews have been published (311, 313, 443, 449) . In brief, the activation since the muscle fiber has adapted to have an optimal economy for a given velocity (153, 158, 435) .
of protein synthesis is a rapid and rather homogeneous phenomenon. Schreiber et al. (406) showed that total proThe adaptational process is dominated by several changes in genetic expression that allow the heart to re-tein synthesis, including myosin, but not myoglobin, and collagen, were activated after 3 h of increased aortic prescover a normal economy. Quantitative modifications lead to cardiac hypertrophy and, according to Laplace's law, sure. Hatt et al. (189) were able to demonstrate polysomes in the myocardium 30 min after an acute overload. Followwill normalize the wall stress. Simultaneously qualitative changes will allow the myocardial fiber to contract more ing the imposition of a pressure overload, such as aortic stenosis, radioactive labeling of total proteins or myosin slowly and to recover a normal economy by having a lower V max and by using a different force-velocity curve remained unchanged for 1 or 2 days, peaked at 5-6 days, and returned to control values within 2-3 wk (304, 370, (7, 246, 247) . This phenomenon proceeds by trial and error, and the permanent changes in genetic expression si-527). The accumulation of total proteins or myosin is due to an increased rate of synthesis; nevertheless, the rate of multaneously have, even at the beginning, both beneficial effects in terms of muscular economy and detrimental, or degradation is augmented in parallel, such a paradoxical wasting effect is a general feature in protein metabolism even useless, effects (383) . Cardiac failure, when it occurs, indicates the limits of the process of biological adap- (304, 313) . Molecular biological techniques using global approaches such as hybridization curves to evaluate tation (448) .
The phenotypic changes (also called phenoconver-mRNA complexity were unable to detect major differences between normal and hypertrophied hearts (26, 450) . sion) are very similar in a variety of conditions, including fetal development, volume and pressure overload, senes-Different results were subsequently obtained using more sophisticated techniques such as differential display and cence, or hypothyroidism. This coincidence is not fortuitous, since in each of these conditions the change in specific hybridization procedures and are described in section VIII. genetic expression is due to an external event, and the same program is always used simply because this is the only developmental program available (266).
D. Energy Metabolism

C. Cardiac Hypertrophy
Energetics
To quantitate the economy of a system, it is necessary The increase in cardiac mass is the most easily detectable adaptational factor triggered by mechanical overload. to measure the mechanical performances such as force, or force-time integrals, or work (economy is then termed 340, 449). Of course, it is easy to oppose two extreme conditions, i.e., CF due to acute anoxia and CF occurring a few efficiency) and the corresponding energy flux. Energy flux can be quantitated by measuring ATP or oxygen consump-weeks after massive MI and involving an important loss of contractile material. Nevertheless, these are rather rare tion or heat production. A major technical progress was made following the invention of a microthermopile that situations that are unrelated to CR as it is usually met in clinical practice. The real problem is to know whether, durallowed Alpert's group (6, 7, 183) to measure heat production in the rabbit papillary muscle as well as in strips of ing the compensatory stage, modifications in the cellular apparatus that are responsible for energy production (mitohuman cardiac muscle on a beat-to-beat basis (Fig. 1) .
The heart, as any other muscle, uses energy for sev-chondria or anaerobic energy pathways) could account for further impairment of myocardial function or, conversely, eral purposes: 1) for the processes responsible for the survival of the tissue, such as protein synthesis and ion could CF be more easily explained by a deficit in energy utilization at the level of the contractile machinery. movements (''resting heat''); 2) resynthesis of the highenergy phosphate stores, which mainly occurs in mitoMyoglobin facilitates the transport of molecular oxygen from erythrocytes to mitochondria and plays an imchondria but can depend on the anaerobic glycolytic pathway during ischemia (''recovery heat''); 3) contraction portant role in myocardial oxygenation. A 40-50% reduction in myocardial myoglobin protein and mRNA has been (''initial heat''), including ATP hydrolysis for cross-bridge cycling (''tension-dependent initial heat''), and excitation-well documented in various models of congestive CF, including CF in humans (335, 336) . Such a reduction would contraction coupling (''tension-independent initial heat'').
The fundamental process of adaptation that occurs affect the energy flux in the myocardium and could be considered to participate in the energy deficit that is assoduring mechanical overload, both in human and in experimental models, includes a slowing of V max with a diminu-ciated with CF.
In CCH, mitochondria adapt to the new situation by tion of the heat produced per gram of active tension during contraction. Both the resting and recovery heats re-increasing their number and decreasing their size. The mitochondrial mass increases (188) by activation of mitomain unchanged. Special experimental protocols allow one to partition heat produced by the sliding process, chondrial DNA replication and by removal of the block in the conversion of DNA D-loops to other intermediates from that produced by the movement of calcium and the activity of the different calcium pumps. Both systems are (364). The mitochondria-to-myofibril ratio remains unchanged, but even with a decreased ratio, the efficiency of used during contraction, and both function more economically during cardiac hypertrophy in animal models and the organelles would be normal or even improved because fragmentation enlarges the average surface area for oxyin end-stage CF in humans (6, 7, 183) .
In conclusion, 1) the reduction in V max is the main gen exchange. This kind of morphological adaptation occurs in every model of cardiac hypertrophy, including basic process responsible for myocardial adaptation to mechanical overload. Thermodynamic data have sug-aorta-caval fistula, which is a model of pure mechanical overload without any neurohormonal modification (188, gested that this reduction is due to a decreased recruitment of myosin cross bridges. Such modifications already 189). In vitro studies showed normal or even improved mitochondrial oxygen function and coupling (reviewed in exist in the compensated stage. 2) In sharp contrast to the current bedside opinion, the diminution of V max has a Ref. 449) and, as discussed in section IIID1, heat recovery (which depends of mitochondria activity) is not modified beneficial event at least at the myofiber level, since it allows the cardiac fiber to contract at a normal energy in CCH (Fig. 1) . In addition, more recent studies based on 31 P-NMR spectroscopy showed no significant differcost. Nevertheless, at the organ level, the diminution of V max is also the first step that will finally lead to a decrease ences in either the content or turnover rates of the phosphoryl group in CCH (211, 212). Oxygen and substrate in cardiac output and finally to failure. 3) Perturbed mitochondrial oxidative phosphorylation and anaerobic en-uptake measured in vivo by estimating arteriovenous differences with a catheter in the coronary sinus were unergy metabolism are both unlikely candidates to cause CF, since the recovery heat remains unchanged (despite changed in cardiac hypertrophy (40) .
Rather ancient studies reported a lactate dehydrogea 20% decrease which is not statistically significant; Fig.  1 Table 2 ). The myocardial creatine phosphate-to-ATP ratio Mitochondrial function Å (449) f (Ischemia?) (40) can be more directly assessed in situ on beating hearts atine kinase (in rat) and a creatine deficit and changes in creatine kinase activity (in cardiomyopathic hamsters) have also been described during CCH (323, 465, 517) . ity of enzymes responsible for ketone body metabolism (including acetoacetyl-CoA synthase). This suggests that Hence, it is impossible to conclude whether such a deficit originates early during the development of the adaptathere is a preferential utilization of glucose when compared with ketone bodies as competing substrates for the tional process or is only created or aggravated by other external factors during CF. fuel of cardiac respiration (225, 454) . There is no doubt that the rate of glycolysis from exogenous glucose is accelerated in cardiac hypertrophy. Recent studies have E. Membrane Proteins strongly suggested that this process is regulated at the level of membrane enzymes, since myocardial glycogen 1. Ion channels and currents metabolism does not change (4) . A gene regulatory mechanism involved in the reexpression of the gene encoding
The increased Q-T (and Q-Tc, which is the Q-T interval corrected for heart rate) interval duration on electrocardiomedium-chain acyl-CoA dehydrogenase (which catalyzes a rate-limiting step in the fatty acid oxidation) has been gram (ECG) and the enhanced action potential duration on isolated cardiomyocytes are well-documented characterisidentified (388) . This mechanism involves reactivation of fetal transcriptional control via members of the Sp and tics of the hypertrophied heart and cardiocyte ( Table 4) .
The duration of the action potential duration depends on chicken ovalbumin upstream promoter transcription factor (COUP-TF)/erbA-related protein families of transcrip-the activity of several ion channels and can increase either when an outward current is depressed or when an inward tion factors and is likely to be also involved in the reexpression of the skeletal actin isoform. current is enhanced. The modifications of these current activities could result from either functional or structural In CF, several rather ancient studies had initially suggested that myocardial ATP content was normal (357, re-changes. At present, there are enough data to support the second hypothesis. Structural changes are mainly due to viewed in Ref. 449), even in humans (84), and that energy depletion was a consequence and not the cause of CF modifications in the expression of genes encoding ion channels. Acquired modifications of the repolarization time prob- (357) . More recent studies have contradicted these findings, and CF has been reported to result in the depression ably reflect the adaptational response compensating for the mechanical overload such as the isomyosin shift. Recent of mitochondrial function and a modification in several of the mitochondrial enzymes including malate and gluta-studies on an inherited monogenic multiallelic disease, the long Q-T syndrome, have demonstrated that a prolonged mate dehydrogenase (349) . Other studies have also revealed a decreased oxidation of fatty acids in the failing action potential can indeed be caused by several mutations located on ion channel genes including a subunit of the heart (512). These alterations are probably a consequence of the neurohormonal imbalance and ischemia that are sodium channel, and HERG, which encodes the a-subunits of a potassium channel. The electrophysiological pattern associated with CF (Table 3 ). It has also been suggested that the failing heart is ''energy starved'' (229) and that observed during CCH and CF has recently been reviewed (18, 181, 447, 448) . its capacity to synthesize ATP via the creatine kinase system is impaired. The pioneer studies of Ingwall and co-1) The slow inward current I CaL contributes to the 489, 490) (Table 4) .
2) Sodium/calcium exchange creates an inward depo- found in the atria of young subjects (100). The relative contribution of the cloned potassium channels to cardiac function has only been partly eluciplateau phase and could be involved in lengthening the action potential provided that the corresponding current dated (106) . A major advance concerning CR was the discovery, by El-Sherif and co-workers (155) , that the elecdensity is increased. The changes in inward current are strongly correlated to the density of the dihydropyridine trophysiological modifications of the two components of I to , I to-s and I to-f , reflect changes in the genetic expression tion system (520), is reexpressed in the overloaded rat ventricle (77) . 4) In addition, an increased susceptibility of the corresponding potassium channels at the level of both the protein and the mRNA. The expression of Kv1.4 to pacemaker-like activity has been demonstrated in human trabeculae from failing hearts during superfusion and Kv2.1, which, for these authors, are genes encoding I to-s , and that of Kv4.2, which is the gene encoding I to-f , with a modified Tyrode solution (482).
The reappearance of I f , I CaT , and the a 3 -isoform of are decreased by 60 and 54%, respectively, suggesting that the diminution of I to and the corresponding lengthening the Na / -K / -ATPase is suggestive of the reinduction of a fetal program (such a program is also expressed in the of both action potential and Q-T interval are in fact transcriptionally regulated and participate in the adaptational adult conduction system). Attempts to trigger automaticity in pure models of CCH by increasing the external calprocess.
In feline models of cardiac hypertrophy, the delayed cium concentration have, however, been unsuccessful (15, 72, 73). rectifier outward current I K is also reduced, whereas the background inward rectifier current I K1 is increased. Connexins are components of the gap junctions; they are confined to intercalated disks and constitute the ing CF in humans, convincing reports have shown that the prolongation of the duration of the action potential channels that establish cell-to-cell electrical coupling.
There is evidence of a rather complex rearrangement of is, at least in part, caused by I to , since 3 mM 4-aminopyridine, a specific inhibitor of I to , does not entirely restore a connexin distribution in CR both in human and experimental models with a shift in genetic expression from normal duration (29, 98) . Moreover, there is a coordinated decrease in I to and I K1 . The delayed rectifier is hardly connexin43 (the most abundant ventricular connexin isoform) to connexin40 (which is normally only expressed detectable and plays only a minor role in the human cardiocyte (35) .
in atria and in the conduction system and has a greater unitary conductance than connexin43 and -45) (24, 348). A major advance in our understanding of the modifications in ion channels was made by Nuss et al. (334) Connexin40 is increased in CR, and the accumulation of this molecule may explain the increased susceptibility of using gene transfer technology and the canine tachycardia-induced model of CF. In this model, isolated cardio-the hypertrophied heart to arrhythmias. cytes have prolonged action potentials that are due to a 66% reduction in I to . A genetic construct was made using 2.
Control of intracellular pH an adenoviral shuttle vector and the Drosophila Shaker
There is little information available concerning the B (ShK) gene as a prototype of the voltage-dependent control of intracellular pH (pH i ). The Na / /H / antiporter class of potassium channels. Failing cardiocytes were in-is a polymorphic transmembrane protein that participates fected with the genetic construct. Two to three days after in the regulation of pH i . Pressure overload in the rabbit infection by ShK, the action potentials were dramatically results in a twofold increase in the Na / /H / antiporter shortened in a dose-dependent manner. In other words, isoform NHE-1 mRNA 3 days after the beginning of the it is possible to correct the increased repolarization time load, and this level remains constant for 2 wk. It was by gene transfection with potassium channel genes, and proposed that this activation is involved both in the reguin so doing to increase the contraction velocity which lation of pH i and as an intracellular signaling system (459) . then returns to control values. This is the first demonstra-The same type of activation has been observed following tion that one of the primary events in the adaptational ischemia (139). In contrast, the activity of the exchanger process is located at the level of ion channels.
is reduced in the diabetic heart in response to alterations 4) At least three currents or proteins specific for in intracellular calcium (250). As yet, there is no additional the sinus node have been found in overloaded ventricles, information concerning the other main determinants of suggesting that the ventricles are able to acquire some pH i , namely, the intrinsic buffering power, the Na / -HCO 3 degree of automaticity. 1) Cerbai and co-workers (72, 73) cotransporter, and the Cl 0 /HCO 3 exchangers in CR. have recently shown the spontaneous occurrence of I f (the main current responsible for the spontaneous depo-3. Calcium-regulating proteins larization of the pacemaker) in isolated ventricular myocytes from senescent SHR. A good correlation exists beIntracellular calcium participates both in the control of the contractile process and in the coupling between tween the duration of the pressure overload and the number of cells in which this current is found. 2) Reexpression mechanical activity, energy metabolism, and most likely protein synthesis. The free cytosolic intracellular calcium of I CaT , a calcium channel insensitive to calcium blockers and specific for the sinus node, has been demonstrated in cardiac tissue, as in every tissue, has two origins: the extracellular space and a closed internal store, called the in the hypertrophied ventricle (333) , although there is indirect evidence that this channel is not functional (15). 3) sarcoplasmic reticulum (SR). From a purely molecular point of view, the intracellular calcium homeostasis and More recently, we have found that the a 3 -isoform of the sodium pump, which is probably a marker of the conduc-calcium transient depend on various proteins that are re- / -ATPase, the latter, also called the sodium pump, pro-(262) that 1) the cardiac isoform is unique (239, 404) and vides energy for calcium transfer at the external mem-does not shift to another isoform during cardiac overload. brane level. In contrast, input of calcium into the cytosol 2) Both mRNA and protein concentrations decrease in is controlled by gated systems, namely, the ryanodine re-proportion to the degree of cardiac hypertrophy. This sugceptor of the SR, which is responsible for the calcium-gests that the corresponding gene is not activated by meinduced calcium release phenomena, and the calcium chanical overload that results in a dilution of both the channels for the external membrane (reviewed in Refs. corresponding mRNA and protein.
3) The oxalate-stimu-14, 494) (Fig. 2) . lated calcium uptake, an essential property of the SR, is impaired. This alteration is due to a parallel reduction A) SARCOPLASMIC RETICULUM. An altered calcium uptake by the SR of failing myocardium has been reported in the functionally active SR Ca 2/ -ATPase molecules, as determined by quantitation of the calcium-dependent several times over the past 25 yr (216, 254, 436). However, convincing evidence for this has only recently been ob-phosphorylated intermediate (25) . 4) The diminution can be correlated with the force-frequency curve (184) , the tained by routine use of molecular biological techniques. A decreased concentration of the SR Ca 2/ -ATPase in cardiac index (294), and the levels of brain and atrial natriuretic factors (13, 456) and Na / /Ca 2/ exchanger CR, regardless of the etiology or model, has now been well documented. To date, the diminished expression of (433) . In a comparative study, Schwinger et al. (415) have shown that the purification procedure may normalize the SERCA2a, the gene encoding the cardiac isoform of the enzyme, is considered to be one of the best markers of observed modifications and has suggested that additional factors could regulate the activity of the SR Ca 2/ -ATPase, chronic cardiac overload. The reduction in the concentration of the enzyme is progressive and is linked to the a suggestion which has also been made for the ryanodine receptor (389) (see below). Such modifications have also progression of cardiac hypertrophy, which in turn is corre- been reported in experimental models of CCH (25, 283, Two forms of intracellular calcium-release channels are expressed in the heart: the ryanodine receptor and 318) and in end-stage CF in humans (Table 5 ). Because SR Ca 2/ -ATPase activity is almost absent in 14-day fetal the inositol 1,4,5-trisphosphate (IP 3 ) receptor (66, 157) . The situation for the ryanodine receptors is rather complirat hearts and increases substantially at the end of the fetal life and in the early postnatal period to reach a maxi-cated. In experimental CCH, in rat, rabbit, guinea pig, and ferret, the ryanodine receptor binding site density is mum 4 days after birth (264) , it is generally accepted that the diminished concentration observed during cardiac reduced and parallels the Ca 2/ -ATPase concentration, with a more severe alteration being present in ferret, raboverload participates in the reexpression of the fetal program (Table 2) . Adenovirus-mediated expression of a bit, and guinea pig than in rat (283, 322, 365) . In end-stage failure in humans, several investigators, including those SERCA2 transgene can reconstitute endogenous SERCA levels and activity obtained in cultured neonatal cardio-from our laboratory, dealing with a sufficient number of experiments, found a decreased mRNA content and an cytes treated with phorbol 12-myristate 13-acetate. It is conceivably possible that in the future it will be possible unchanged protein level (Table 5 ). In addition, binding studies using radioactive ryanodine revealed a twofold to correct the above modification using gene transfer technology (156) .
increase in the number of high-affinity sites (231, 389) with an unchanged dissociation constant, suggesting that Phospholamban and calsequestrin have also been investigated both in experimental models and in humans. during CF additional regulatory factors affect the ryanodine binding properties. Supporting the latter hypothesis A drastic diminution of phospholamban has been reported in the human heart with end-stage failure (13, 14, 297) are the differences in the gating properties of the caffeineinduced calcium release observed by D'Agnolo et al. (103) and in experimental cardiac hypertrophy (232, 283, 318) . In both cases, the fall more or less parallels that of the and by Kim et al. (231) , the decreased ryanodine calcium accumulation into SR in cardiomyopathic human hearts SR Ca 2/ -ATPase and might play a role in the attenuated response of the contractile apparatus to catecholamine. (329), and the fact that ryanodine binding is affected by the purification procedure (329, 389). Another possibility The targeted cardiac overexpression or knockout of phospholamban has confirmed the important role of such a is that the downregulation of the ryanodine receptors would be compensated, at least in humans, by an upreguprotein in regulating both relaxation and contraction (224, 270) . In contrast, calsequestrin remained unchanged, ex-lation of the IP 3 receptors (157) .
To summarize, in CCH, the proteins responsible for cept in the rabbit model (283) (Fig. 2) . This process is not species specific, and the total number 113, myocardial infarction in rats. of calcium channels parallels the degree of cardiac hypertrophy in at least two different animal species (rat and guinea pig) that have different mechanisms of calcium me-a 1 (a 1 b) (75%) and a 2 (a 2 b) (25%). A third isoform, a 3 , is mainly embryonic but is also present in the conductive tabolism (361). As explained above, additional isoform modifications occur which, for the moment, have no electro-tissue of normal adult hearts (520). This enzyme has two important properties, namely, its affinity for sodium and physiological significance (154).
Different results have been observed in end-stage CF for ouabain. In rats, a 3 has a low affinity for sodium and a high affinity for glycosides. In contrast, a 1 , which has a in humans. Beuckelmann et al. (34) found in CF the same type of results as those obtained in CCH, namely, an un-higher affinity for sodium, has a low affinity for ouabain and is likely to be responsible for digitalis toxicity (76, changed density of I Ca . In contrast, others have reported a pronounced and parallel reduction in both dihydropyri-79). Studies during CCH in the rat using a highly purified membrane preparation (276) have shown a complex patdine receptors and in the level of mRNA encoding the a 1 -subunit of the calcium channel (Table 5) . Interestingly, a tern (76, 77, 249) that combines 1) an unchanged specific activity, 2) an increased density in the high-affinity sites reduction in the calcium channel concentration has also been observed in intact myocytes from chick embryo ven-for ouabain, and 3) a slowing of the dissociation rate constant (k 01 ) for ouabain (Table 6 ). Such modifications tricles after a 4-h exposure to 1 mM isoproterenol, in parallel to a downregulation of the b-adrenergic receptors reflect an isoenzymic shift of the a-subunit from the adult form, a 2 , to the fetal form, a 3 . The a 3 form has a much (281), thus suggesting that the decrease in the number of the calcium channels observed during CF is in fact a lower affinity for sodium than a 2 , and this shift finally results in a lower affinity of the overall enzyme for sodium. consequence of the neurohormonal disorders which accompany the hemodynamic failure. Both the receptor This would mean that, in the rat, the sodium pump should be less active in cardiac hypertrophy. level and related voltage-sensitive calcium channels increase in the Syrian cardiomyopathic hamster; nevertheThe situation is clearly species specific and is different in humans. In the failing human heart, the activity of less, such an alteration is likely to have a genetic origin and has simultaneously been observed in heart, brain, and the Na / -K / -ATPase is reduced, and it is less sensitive to sodium (417) . Molecular biological studies on the a-subskeletal and smooth muscles (489) .
Calcium output is mainly regulated by a functional unit of the enzyme, made on a limited number of cases, have found a shift from the a 1 -to the a 3 -isoform. Because duo composed of the Na / /Ca 2/ exchanger and the Na / -K / -ATPase. The first is responsible for the calcium release, the human heart possesses an a 1 -subunit with a low affinity for sodium, one can conclude that in humans, as in rats, whereas the second provides energy to the first. Both are modified in CCH, suggesting that calcium homeostasis the final result is a diminution of the affinity of sodium for the enzyme and then a slight accumulation of sodium may be unbalanced at this level.
Several papers have shown alterations in the activity below the membrane surface ( Table 6 ). The activity of the Na / /Ca 2/ exchanger has been a of the Na / -K / -ATPase, the so-called sodium pump (360, 516). More recent studies using molecular biological tech-controversial issue. Pioneer studies in rats using isolated membrane vesicles during both cardiac overload and in niques have shown modifications in the sodium pump that are species specific. The Na / -K / -ATPase is composed of the senescent heart have concluded that the activity of the exchanger was depressed (113, 114, 176, 198) . Such two subunits, a and b. The a-subunit is polymorphic, and the normal adult rat heart contains two different isoforms, results have been contradicted by investigations per-formed using new molecular tools. Such contradictions can be induced by a variety of hypertrophic agonists, including catecholamines and endothelin-1 (378). may be due to the fact that the membrane vesicles are heterogeneous in size and that the procedure used for A) b-ADRENERGIC AND MUSCARINIC RECEPTORS AND THEIR TRANSDUCTION SYSTEM. The positive inotropic and their isolation does in fact select different vesicles in the different experimental groups. It has now been generally cAMP-elevating effects of b-adrenoceptor agonists and phosphodiesterase inhibitors are attenuated in the hyperaccepted that the molecular density of the Na / /Ca 2/ exchanger is increased during both compensatory hypertro-trophied nonfailing and failing heart and also during senescence. The inotropic response to calcium, dibutyryl phy and in end-stage CF in humans (433, unpublished data) (Fig. 2) . The increased expression of the exchanger cAMP, or ouabain is unmodified (44, 56, 63, 81, 133, 400) .
During CF, isoproterenol is unable to compensate for the can be correlated with the reduction in the Ca 2/ -ATPase of the SR (433) . The Na / /Ca 2/ exchanger is an electro-excitation-contraction uncoupling (160) . The isoproterenol-induced increase in the calcium transient is maingenic transporter that generates the current I Na-Ca . The corresponding potential E Na-Ca becomes more and more tained (37) , suggesting that there is a defect located ''down the road'' (166). The regulation of receptor density positive as the intracellular calcium concentration increases. For this reason, the exchanger generates an in-is a species-specific phenomenon (99).
Following the pioneer studies of Bristow and coward depolarizing current during almost all of the duration of the action potential. The prolongation of the cal-workers (56, 57), the cardiac b-adrenergic receptors have been extensively investigated (reviewed in 59) ( Table 7) , cium transient will lengthen the I Na-Ca , and at present, it is thought that the activity of the exchanger is both length-and two situations have been identified. 1) Studies on CCH have shown that, in spite of normal plasma levels ened and attenuated by the slightest increase in intracellular sodium.
and depressed myocardial catecholamine content (147), the b-adrenergic receptor density is decreased by 29%, Very few studies have been carried out on the Ca 2/ -ATPase of the external membrane, which is thought to whereas the b 1 /b 2 -adrenergic receptor density remains unchanged. In addition, competition curves with isoprotereremain unchanged during cardiac hypertrophy (114) . C) CALCIUM TRANSPORT WITHIN THE CELL. Calmodulin is nol have revealed two sites, one with a high affinity and the same inhibition constant (K i ) (2-8 nM) as in normal a four-calcium site binding protein that acts as a cofactor in numerous reactions. A reduction in the amount of cal-hearts, and the other with a low affinity for the agonist (K i 6-13 mM), which represents an unusual subpopulation modulin mRNA has been reported in failing human hearts (222) . Calmodulin also has a role in myocardial protein of uncoupled receptors (81, 275, 305) . The corresponding mRNA are decreased in parallel (308) , whereas the total synthesis and cell proliferation as shown using transgenic technology (164), and the decreased calmodulin expres-number of receptors per heart remains unchanged, suggesting that the corresponding gene is not activated by sion may also have a significance in terms of growth signaling.
mechanical stress and that the changes in receptor density are regulated. 2) In failing hearts, even in humans, the elevated circulating catecholamine levels induce a homol-4. Cardiac receptors ogous downregulation of the b 1 -adrenergic receptor, and this creates an additional decrease in the receptor density A rather large number of receptors have been identified in the adult human heart, including seven domain that is superimposed onto the heterologous downregulation occurring during the compensation. The downregulamembrane receptors, such as the adrenergic, angiotensin II, and muscarinic receptors, as well as nuclear DNA-bind-tion that occurs during CF is specific for the b 1 -adrenoceptor subtype and, at least in dilated cardiomyopathy, does ing receptors such as aldosterone, thyroxine, and glucocorticoid receptors. Numerous changes in the expression not affect the b 2 -subtypes. Such a selective subtype regulation is controversial as far as ischemic cardiopathy is of most of the known myocardial receptors as well as modifications in the functioning of the corresponding sig-concerned and does not exist in mitral valve disease (59).
The downregulation of the b-adrenergic receptor is a comnal pathways have been reported to occur during CR both during compensation and failure (Table 7) . Such modifi-plicated dose-and time-dependent phenomena and requires a preliminary phosphorylation of the receptor cations most likely have a dual origin and reflect both an adaptation to the mechanical stress, i.e., a heterologous through a specific b-adrenergic receptor kinase whose expression is reduced in CR (475). Targeted overexregulation, and additional homologous regulations in response to changes in the plasma levels of the correspond-pression of this enzyme using transgenic technology attenuates the isoproterenol-induced increase in cardiac coning agonists. The concentrations of both a 1 -adrenergic and adenosine A 1 receptors are unchanged in CF (1, 45, 58) ; tractility (236) . b 3 -Adrenoceptors are present in the human myocardium, but for the moment, their pathophysnevertheless, it has been proposed by Simpson, who discovered the direct hypertrophic effect of a 1 -adrenergic iological role has not been documented (149) .
Reflex bradycardia, in response to baroreflex hyperagonist (424) , that the a 1C -adrenergic receptor subtype tension, is attenuated in CF, which indicates an additional 324). Such an alteration could account for the discrepancies between changes in adrenoceptor density and the adedefective control at the parasympathetic level in this disease. Muscarinic receptors and mRNA are also downregu-nylate cyclase-stimulating effects of agonists. Prolonged infusion of isoproterenol (2.4 mgrkg 01 rday 0 ) not only lated in CCH (275, 308) , and, at least in the rat, the muscarinic-to-b 1 -adrenergic receptor ratio remains unchanged, reduces the b-adrenoceptor density and the adenylate cyclase activity, but it also increases the cardiac level of suggesting that they reflect a compensatory mechanism more than a homologous downregulation. Pressure over-Ga i-2 . On the basis of the studies of isolated cardiomyocytes, it is now generally accepted that there is a transcripload accompanied by CF in dogs lowers the muscarinic receptor density by 36%. This loss is rather specific for the tional cross-regulation of G protein pathways. The increased level of this particular G subunit in CF is most high-affinity population and is associated with a depressed functional efficiency of the muscarinic system (478). How-likely to be caused by elevated levels of plasma catecholamines (125, 126). ever, in this article, receptor density was measured on a highly purified membrane preparation. At present, the Muscarinic regulation may have important effects on cardiac function in CF. Such a question has recently been situation is far from being clear, and the previous results have been contradicted by Fu et al. (144) and by Bö hm addressed by Newton et al. (325), who found in the failing human hearts, and not in controls, a negative effect of et al. (45) , who found normal muscarinic receptor content in the failing heart of rats after MI. muscarinic stimulation on myocardial relaxation, and by Eschenhagen et al. (125) , who showed in rats that chronic One of the most prominent features of CF in humans, which has been confirmed by three different laboratories, treatment with carbachol favors the occurrence of isoprenaline-induced arrhythmias. is the existence of a 35-40% increase in the level of the Ga i subunit, whereas Ga s remains unchanged. Molecular
The adenylate cyclase activation by isoproterenol, 5-guanylylimidodiphosphate, and forskolin is reduced, and biological studies have revealed that this augmentation is due to a 75% increase in Ga i-2 (in the human heart Ga i-1 this reduction is accompanied by a comparable reduction of the isoproterenol and forskolin activation of myocardial is almost absent and Ga i-3 is unchanged) (45, 125, 132, contraction (44, 58, 81, 126) . Recent investigations using by Regitz-Zagrosek et al. (371) . It was subsequently shown that the decreased receptor density was accompanied by molecular probes specific for adenylate cyclase isoforms showed in CF a decreased type VI adenylate cyclase iso-a parallel diminution in the mRNA levels. In addition, ATR1, but not ATR2, was significantly altered (17, 192) , form, which is the minor isoform in the rat heart; such a diminution may explain in part the depressed activity (127). as in experimental MI. The drop in ATR1 density is correlated with a decrease in b 1 -adrenergic density, suggesting The decreased b 1 -adrenergic receptor density protects the heart against acute stress and, in CCH, partici-that the two phenomena have a common origin and may be related to the increased plasma levels of the correpates in the overall process of cardiac adaptation by attenuating the inotropic effects of catecholamines. As such, sponding agonists (17). noninduction of the genes encoding this system has the same significance as noninduction of the SR Ca 2/ -ATPase or the isomyosin shift to the slow isoform V 3 .
F. Contractile Proteins B) ANGIOTENSIN II RECEPTORS. Angiotensin II receptors (ATR) are expressed at a rather low density in the heart, 1. Isomyosin shift to V3 including the human heart, as compared with the b-adrenergic receptors (Table 7 ). In rats, ATR predominate in the The myosin molecule is composed of a pair of myosin heavy chains (MHC) and two different pairs of myosin atria and in the conduction system (391). At present, three different receptor subtypes have been identified: ATR1 a , light chains (MLC), MLC1 and MPLC2. In the rat heart, there are three isomyosins: V1, V2, and V3, all of which ATR1 b , and ATR2. The ATR1 are responsible for both the vasoconstrictive and inotropic effects of the peptide. Tro-possess the same pairs of MLC, MLC1v, and MPLC2v, but which differ by their MHC composition, aa in V1, ab in phic effects differ according to the target cell and are mediated by the three subtypes through multiple path-V2, and bb in V3. The fast skeletal myosin is composed of a different pair of MHC and MLC molecules, but the ways, and the exact role of ATR2 has not been defined (reviewed in Refs. 372 and 387). The normal rat and hu-slow skeletal isomyosin is very similar to V3, since it is composed of the same MHC molecules, bb, and MLC1 man heart contains 30-60% ATR1 and 70-40% ATR2 (330, 371). In humans, ATR1 are located both on myocytes and molecule, MlC1v (also termed MlC1s), but differs from V3 by a specific MPLC2 molecule. The myosin ATPase-active on nonmuscular cells (17, 379).
Cardiac remodeling following experimental MI in-site is located on the MHC head and depends on the structure of these subunits, the aa-isoMHC has the highest duces changes in ATR as initially shown on isolated cardiocytes by Meggs and co-workers (291, 525) (Table ATPase activity, whereas the bb-one possesses a low enzymatic activity. In phylogeny, when different muscles 7). Reactive hypertrophy was accompanied by almost a twofold increase in ATR1 density, which parallels the de-from various species are compared, a good correlation has been found between myosin ATPase, i.e., the type of pression in the velocity of myocyte shortening and relengthening. Using competitive PCR and binding assays, MHC isoform, including ''superactivated'' ATPase (245) and V max in various conditions including mechanical overNio et al. (330) analyzed the receptor subtypes and demonstrated that MI in rats causes a two-to fourfold increase load, thyroxine intoxication, and the right to left ventricle differences (61, 115, 412, 442). in ATR1 a and ATR2, with no changes in ATR1 b , both in the infarcted and noninfarcted areas. Nuclear run-off showed In response to chronic mechanical overload, genes from various striated muscles respond in the same way that these changes are transcriptionally regulated. Such an augmentation occurs soon after acute infarction in the whatever the muscle type, i.e., atrial, ventricular, or fast skeletal muscle. The response is 1) an inhibition of the zone of acute ischemia and then remains located in the scar tissue and noninfarcted fibrotic area (439). Therapy expression of those genes coding for fast MHC, a-MHC, in the heart and MHCf in the skeletal muscle, and 2) an with an ATR1, but not with an ATR2, antagonist reduces this increased expression.
activation of a unique gene, b-MHC, in all three muscles. Such harmonious and complex regulations require a comResults concerning CCH are more controversial as shown Table 7 , mainly because these studies have been mon mechanism for the two muscles and for the three genes, a-MHC, MHCf, and b-MHC. The regulation is performed on very limited number of experiments. In several reports, except two (267, 513), models of CCH, includ-mostly, if not entirely, transcriptional.
The first evidence of qualitative changes in the molecing SHR, renal hypertension (441), and abdominal aortic stenosis (128), result in substantial increases in ventricu-ular structure of the overloaded heart was made in our laboratory and consists of a MHC shift observed in the lar ATR with an unchanged ATR1-to-ATR2 ratio (Table  7) . Cardiac hypertrophy is also partially prevented by type overloaded rat ventricle (266). Subsequently, similar modifications were confirmed by numerous groups in different 1 receptor blockade (128).
The as well as in mice (115) . This isomyosin shift can be re-content of specific atrial light chains, the ventricular MLC subtypes, MLC1v and MPLC2v. In addition, in various huversed by treatment with CEI (298) .
In the heart, these isomyosins depend on both the man cardiomyopathies, the ventricles become enriched in the embryonic MLC isoform, MLCemb (which is also in type of animal species and the type of muscle (atria or ventricle). Both the V max and the myosin composition of fact the MLC expressed in the atria, MLCemb Å MLC1a) ( Table 2 ). The functional significance of these various the ventricles vary from one species to another. In the rat, the aa-isoform is predominant; in contrast, the normal modifications is still unclear, although it has been shown that the amount of embryonic MLC reexpressed in the human ventricle is entirely composed of the slow MHC isoform bb. In the rat ventricle, cardiac overload rapidly ventricles is correlated with the degree of ventricular wall stress and that after valve replacement the amount of induces (within 2 h on an isolated heart; Ref. 107) a shift from the aa-to the bb-MHC isoform (266, 295). In hu-embryonic MLC returns to a normal level (205, 440) .
In the heart, V max is obtained by extrapolation from mans, as well as in some other mammalian species, this shift occurs, but it is of minor importance, since the hu-the force-velocity curve and is a complex function of many variables. In fact, V max is sensitive to both the rate of crossman ventricle is already composed almost entirely of the bb-MHC (50, 51, 293). In human ventricles, it has been bridge cycling and the number of active bridges, and a new mechanism of regulation located at the level of the demonstrated that the a-MHC which exists as a minor isomyosin component is transformed into the b-MHC iso-cross-bridge cycling and different from the isomyosin shift has been proposed. The cAMP-induced inotropic reform (49). Myosin ATPase isolated from human ventricles is unmodified by mechanical overload, even when it is sponse, which is known to involve an activation of the calcium channels, also has a direct effect on a given isofully activated by cross-linking with actin (245) . Ventricles of baboons contain two immunologically distinct isoforms myosin. Mechanical overload may have a direct effect on cross-bridge cycling through an isomyosin-specific mechof b-MHC, called b 1 (molecular mass 210 kDa) and b 2 (molecular mass 200 kDa); b 1 is the major component and anism analogous to that described for cAMP (206, 509) .
This provides an interesting new possibility to explain b 2 (which is clearly different from a-MHC) represents no more than 6% of b-MHC. The a-MHC is absent. Chronically why, in species such as humans, V max is depressed but the isomyosin profile remains unchanged. It has been sughypertensive baboons have pronounced cardiac hypertrophy and changes in myosin, namely, a depressed calcium-gested, although not demonstrated, that the signal responsible for this direct effect on the myosin molecule origiactivated ATPase and an increased proportion of the b 2 -MHC isoform (196) . Baboons are the only animal species nates from the endothelium (509) .
Posttranslational modifications of myosin subunits in which b-MHC heterogeneity has been demonstrated.
After experimental aortic stenosis, the increased have also been reported both at the level of the light chains and the heavy chains. Both types of myosin subamount of b-MHC mRNA precedes by 1 day the protein changes, demonstrating that the level of regulation is pre-units are indeed phosphorylatable peptides. Region-specific changes in both the activity of the MLC kinase and translational (265, 404) . By days 2-3 after aortic banding, b-MHC mRNA was hardly detectable and was restricted to the relative amounts of phosphorylated MPLC2v have been reported 8 wk after MI in rats in the viable ventricle the inner part of the left ventricle and around the coronary arteries of both ventricles. This suggests that the signal (259) and parallel the reduction of myofibrillar activity reported by others in the same model. The physiological originates from the hemodynamic changes (404). During development, nuclear run-on experiments have shown significance of such findings in terms of myocardial function is still debatable, since it has been shown that the that the regulation of the expression of these two genes (and also the actin gene) is transcriptional (43) . specific activity of the enzyme is too low to account for an immediate regulation (discussed in Ref. 442). In every mammalian species so far studied, normal atrial muscle shortens faster than the ventricle. Consequently, the atrial content of the aa-MHC chain isoform 3. Changes in other sarcomeric proteins is always much higher than that of the bb-isoform. Atrial overload is accompanied by a decrease in the content in Thin filament proteins, including the troponin inhibitory component of troponin, are not thought to be modiaa-MHC, which parallels the atrial size determined echocardiographically (49, 292, 470). Hence, in humans, an fied during chronic overload, even though there are few papers dealing with this question. One of the reasons why isomyosin change occurs in atria during CR. Such a change is probably adaptational and occurs in response this question remains open is the repeated finding of a decreased ATPase activity in the crude myofibrils isolated to chronic atrial overload.
from failing human hearts (5, 248, 344) . This enzymatic 2. Other myosin changes change is not accompanied by an isomyosin shift, and it has been suggested that myofibrillar modifications could It was initially shown by Cummins (102) that the overloaded human atria possesses, in addition to their normal be due an isoform shift occurring in the tropomyosin- binding component of troponin (9) . However, this has the fluorescent signals, the force development, and the heat production. It has been most frequently studied on not been confirmed. Genetic studies have revealed point mutations as the cause of hypertrophic cardiomyopathy isolated cardiac strips or myocytes. The use of a protective solution that contains 30 mM 2,3-butanedione monox-(316).
The cardiac and skeletal isoforms of a-actin are en-ime (BDM), a compound which induces muscle relaxation with minor and reversible alterations in calcium movecoded by different genes but have 90% amino acid sequence homology. However, three of the four amino acid ments (BDM strongly reduces calcium conductance, but this reduction is reversible), allows human samples to be differences found between these two isoforms occur at the myosin binding site. The skeletal mRNA isoform has successfully transported and studied (184) . It has been possible to study isotonic contraction on isolated myobeen found to be transiently expressed during pressure overload in the rat (411) . In addition, cardiac development cytes with a video edge-detection system. Chronic mechanical overload increases the action potential and calin humans is associated with an upregulation of the skeletal isoform that represents 60% of the actin in the adult cium transient durations, slackens the initial speed of contraction, and attenuates the heat production normalized heart. This proportion remains unchanged in the hypertrophic heart (42) . There is also cross-expression of these per gram of developed tension (7) even on isolated cardiocytes (105, 115) . two isoforms in certain strains of mice. For example, BALB/c mice express abnormally high levels of a-skeletal actin in the heart, and studies carried out on the myocar-2. Action potential dial contractility in these animals showed that increased levels of the a-skeletal isoform were significantly corre-
The duration of action potential in myopathic hearts is increased. This was initially shown by Gü lch (167) and lated with an increased contractility. These results demonstrate that a contractile protein isoform shift may have then confirmed by many other investigators (34, 171, 353, 448) . More recently, it has been shown that there are a functional significance (197) .
There are no convincing experiments in favor of a regional differences in action potential duration, and in cardiac hypertrophy, the normal epicardial/endocardial deficit in the sensitivity of the contractile apparatus to calcium as a mechanism to explain contractile failure. gradient is thought to be reversed, which provides an explanation for the T-wave inversion observed on ECG in Investigations using chemically skinned fibers showed enhanced maximum calcium activated force but unchanged this condition (420) . Such an enhanced repolarization time is proportional to the degree of hypertrophy (307) calcium sensitivity (with a pCa 50 of Ç6) in the left ventricles of aging SHR with or without CF (347) as well as in and can be averaged and detected using noninvasive Holter monitoring. Indeed, the Q-T interval on the ECG pressure-overloaded rat and guinea pig ventricles (481). In addition, the stretch-induced increase in Ca 2/ sensitivity, represents, in part, the first derivative of the action potential plateau. In cardiac hypertrophy, the Q-T interval inwhich is an essential property of the normal myofiber, is maintained in dilated cardiomyopathy (103) . However, creases; in addition, during CR, the dispersion of the Q-T interval is augmented in parallel with the severity of the different findings have been obtained in human atria from patients suffering from valvular disease. In these condi-disease (3). The duration of the action potential is also frequency dependent and diminishes with increasing stimtions, the pCa curve was shifted to the right, indicating a decreased sensitivity to the cation. This provided a ratio-ulation frequency. In myopathic hearts, the action potential duration decreases with increased stimulation frenale for the development of a new family of inotropic drugs that could enhance the sensitivity of the sarcomere quency, as it does in the control hearts, and in sharp contrast to the decline in isometric tension and calcium to calcium (382) .
The amount of C-protein remains unchanged in fail-concentration (Fig. 3) (353) . As explained above, the main determinant of the increased duration of action potential ing human hearts (310) . A mutation in the C-protein gene is associated with a familial form of cardiomyopathy (48), is probably due the diminished expression of Kv1.4, 2.1, and 4.2, which are genes encoding I to . The measurement demonstrating that a defect in this protein can induce cardiac hypertrophy.
of the Q-T interval is therefore an invaluable tool to quantitate noninvasively one of the biological determinants of the adaptational process, namely, the diminution of the G. Contractile Cycle and early transient potassium current I to . Prolongation and Excitation-Contraction Coupling regional differences of the action potential can predispose the heart to both triggered arrhythmia by favoring the , and a slowing of the rate of diastolic calcium decay in isolated ventricular myocytes. Different results were reported in the aging SHR model using aequorin in papillary muscles with an unchanged calcium transient duration and peak in CCH. In addition, in the decompensated stage, the diastolic calcium concentration was found to be depressed by 30% in the failing heart (37). 01 . He showed that at low stimulation frequency, the peak of aequorin light (which corresponds to the peak intracellular calcium concentration) was unchanged in muscle strips from a failing human heart. When the stimulation frequency was increased to 120 min 01 , both the peak aequorin light and isometric tension increased in strips from normal hearts; in contrast, the failing heart showed a decrease in both of these two parameters (Figure 3 quencies. The same frequency dependency of the contractile deficit was observed in clinical studies (182) . However, different results were obtained at 30ЊC in a low stimhave also demonstrated a lengthening of the calcium transient in both clinical and experimental settings. Two stud-ulation frequency range that resulted in incomplete relaxation (171). ies have specifically addressed this question in models of CCH. In both studies, basal intracellular calcium concenTo summarize, myocyte loss and abnormalities in extracellular matrix (ECM) components are not solely retration ([Ca 2/ ] i ) values remained unchanged (170, 309). In renovascular hypertensive rats, calcium dynamics dur-sponsible for the depression of the depressed ventricular function in CR and are associated with an impairment of ing the contraction-relaxation cycle are affected. Peak calcium is depressed, and the calcium removal phase is pro-the contractile properties of individual cardiocytes. longed (309) . These results differ slightly from those obtained in the model of pressure overload in the ferret in 2. Coupling which the peak calcium remains unchanged and the only abnormality is a prolongation of the calcium transient It is currently accepted that the normal myocardial excitation contraction is a two-step process and includes (170).
During CF, more controversial results have been re-as a first step a voltage-dependent gating of L-type calcium channels, which results in a sudden and local increased ported. In the end-stage failing human myocardium, using Indirect estimation of excitation-contraction coupling has been made by simultaneously measuring action potential and/or calcium transient and twitch force, which shows that, during cardiac overload and in the normal senescent heart, there is an increase in the duration of the transmembrane action potential, the calcium transient, and the contraction time (15, 34, 167, 426, 505) .
A more direct approach is to evaluate the ability of I CaL to provoke calcium release over a fixed time period by measuring the number of calcium sparks and integrat- ] i movements tive excitation-contraction coupling develops during the (426) . Other mechanisms could include modifications of CCH stage that may be a major determinant in the process proteins such as annexins that are known to modify the of CF. The proposed explanation for such an uncoupling ryanodine receptor properties (280, 389). Targeted overwas based on ultrastructural data suggesting that the dis-expression of annexin VI has been shown to modify cartance between the calcium channels and SR structures diac function (168). was increased.
Nevertheless, the overall phenomenon of excitation-3. Calcium homeostasis in CR contraction uncoupling is most probably species and model specific and has even been excluded for example Several experiments provided both direct and indirect evidence that the ability of the hypertrophied cardiac in guinea pigs in which hypertrophy was produced by gradual pressure overload. In this model, CF results in myocyte to buffer any changes in [Ca evidence came from studies using calcium infusions, pressed while unexplained modifications occur in the ryanodine receptor. while indirect arguments were provided by investigations on the sensitivity of the hypertrophied heart to anoxia or ischemia, conditions which are known to dramatically H. Cardiac Autocrine Functions enhance intracellular calcium.
1) Stepwise increase in the calcium concentration of
The heart is an endocrine tissue and is able to proa perfusate of an isolated heart preparation resulted in duce atrial natriuretic peptides, angiotensin II, and even, ventricular fibrillation and spontaneous calcium oscillaas recently shown, aldosterone and catecholamine. There tions at a calcium concentration ú10 mM. Such a threshis evidence that the first two are activated during mechaniold is Ç6-8 mM in the senescent myocardium or in the cal overloading and that catecholamine cardiac stores are Syrian cardiomyopathic hamster even in the prehypertrodepleted. phic stage (177, 178).
2) The normal isolated rat heart becomes stiffer when 1. Atrial natriuretic peptides perfused for 5-10 min in anoxic conditions. This phenomenon is exaggerated in the hypertrophic heart, regardless
The atrial natriuretic factor (ANF) was discovered by of the model used (65, 268) . Such an exaggeration is unre-Hatt and co-workers in 1976 (278) and is normally only lated to high-energy phosphate availability and most likely expressed in the atria. Atrial natriuretic factor is exreflects an impaired calcium metabolism (507) .
pressed in overloaded ventricles in various experimental 3) Several experimental studies have shown that the models of cardiac overload (117, 141, 296, 471), in MI electrophysiological response to ischemia is altered in failing (300), and in CR in humans (13, 134, 135). The ventricular and hypertrophied myocardium with a predisposition to ven-expression of ANF, and of other natriuretic peptides tricular arrhythmias (218, 237, 282, 461, 483, 511).
(brain and C-type natriuretic peptides) (332, 456) , is actuSeveral hypotheses can explain abnormal calcium ally considered to be the best biological marker of ventrichandling in CR. The one which, for the moment, best fits ular overload. It is associated with an increased atrial the firmly established data is the following. biosynthesis, with reduced intra-atrial storage and transit 1) During the compensatory stage, the intracellular time, and increased secretion. The Golgi apparatus is diastolic calcium is normal, but the transient is prolonged denser, with many secretory granules. Atrial natriuretic to allow the heart to contract more slowly and to maintain factor interacts with particulate guanylate cyclase in tarits normal economy, as previously explained (Fig. 2) . Nev-get cells to produce cGMP both in vivo and in vitro; as a ertheless, the cell is incapable of controlling any abnormal consequence, urinary cGMP can be considered as an easinflux of calcium, due, for example, to ischemia, inotropic ily measurable humoral second messenger of the ANF agents or various stresses. When the hypertrophied heart system. Plasma ANF and urinary and plasma cGMP are is submitted to brief episodes of anoxia, or a sudden in-elevated in proportion to the severity of the decompensacrease in calcium load, its capacity to buffer acute stress tion in two different models, i.e., CF due to MI or aging is hampered relative to normal hearts. The activity of the SHR (298-300). The plasma levels of ANF and brain natri-SR is slowed down, both at the levels of calcium uptake uretic peptide were both elevated in patients with hyperand release, which might explain the lengthening of the trophic obstructive or nonobstructive cardiomyopathy, transient as directly demonstrated using gene transfer aortic stenosis, or arterial hypertension; nevertheless, a (156). At the external membrane level, the calcium influx marked overexpression of the brain form seems a special increases in proportion with the degree of cardiac hyper-feature of hypertrophic obstructive cardiomyopathy (332) . trophy; nevertheless, the prolongation of the calcium transient lengthens I Na-Ca . Such a prolongation could in turn 2. Renin-angiotensin system be a specific stimulus that activates the expression of the genes encoding the Na / /Ca 2/ exchanger and the Na / low-A major peripheral factor of adaptation to changes in hemodynamic conditions occurring during CF is the affinity subunit of the Na / -K / -ATPase. 2) During CF, there is a secretion of several hor-activation of the circulating renin-angiotensin system (RAS) and aldosterone production which both contribute mones or peptides, including catecholamines, angiotensin II, endothelin, all of which have a trophic effect (Fig. to maintain a normal arterial pressure by increasing the peripheral resistance and plasma volume (142, 495). Tis-2). The peak of the calcium transient is now decreased, and the myocardial phenotype is again modified. These sue RAS has been demonstrated in both vessels (120) and myocardium (230, 256) . In the heart, positive immunoremodifications may vary depending on the predominant additional factor. Convincing data have shown a de-activity for angiotensinogen has been found predominantly in atria. Double immunogold labeling has shown crease in the density of the calcium channels that may enhance the disturbances in calcium homeostasis. At that ANF is located in specific granules, whereas angiotensinogen is present on both granules and myofibrils (230 
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The angiotensin converting enzyme (ACE), which is a tive and nonselective endothelin receptor antagonist compounds are currently being evaluated and may be theramembrane-bound protein, and renin have also been successfully evidenced in the myocardium, although renin is peutically useful in CF. Endothelin-1 and preproendothelin-1 mRNA were detectable in normal heart and rare (256) or even absent, in the ventricles (120) . As a final result, isolated hearts produce angiotensinogen and lungs and were significantly increased in several experimental models of CF, including a canine model with a angiotensin II (256). Isolated cardiocytes from rats express genes encoding the three components of RAS (525). low cardiac output (503) and the rat model of MI (427, 466) . Such an upregulation peaks 1 wk after the coronary The human heart differs from that of rat in terms of tissue RAS, and its production of angiotensin II uses two differ-ligation, can be correlated with the LV end-diastolic pressure, and is not accompanied by significant changes in ent pathways, namely, the ACE which predominates in the atria and an angiotensin II-forming chymase which the corresponding receptors (466) . In humans, the elevation of plasma endothelin-1 became significant in patients predominates in the ventricles (476, 477) . The functional significance of the above findings has been confirmed by with moderate CF (NYHA class III and IV); nevertheless, as yet, there is no clear evidence of a stimulation of the showing a partial inhibition in the formation of angiotensin II in the human heart by CEI (514) .
myocardial production of the peptide in the failing human heart (504). The myocardial RAS, including angiotensinogen and ACE, is activated by mechanical stretch due to aortic stenosis in rats, in the cardiomyopathic Syrian hamster, by 5. Nitric oxide production volume overload in the dog, and also in the senescent left
In normal conditions, optimal circulatory homeostaventricle (22, 109, 110, 199, 200, 230, 408, 506) . The activity sis is achieved by a delicate balance of vasodilator and of the ACE is increased by almost fourfold after thoracic vasoconstrictor mechanisms that is modified in congesaortic stenosis in rats (408, 409). Hypertrophied cardio-tive CF. It has recently been shown that nitric oxide (NO) cytes have been isolated from the failing myocardium 7 plays an important role in this type of regulation. In addidays after coronary artery narrowing and have been found tion, NO can exert a negative inotropic and cytolytic effect to contain more renin, angiotensinogen, ACE, as well as on myocytes. The cardiac autocrine function undoubtedly angiotensin I and II than controls (525). Direct assessment plays a role in this delicate peripheral adaptation proceof angiotensin I and II levels in canine myocardial intersti-dure. tial fluid were obtained by using microdialysis probes and Basal circulating NO levels nearly double in idioshowed levels ú100-fold higher than plasma levels that pathic dilated cardiomyopathy (510); in contrast, the caare not affected by intravenous injection of angiotensin pacity of the endothelium to release NO on stimulation is II or CEI, suggesting that angiotensin II production or reduced (118, 173) . A selective enhancement in a 2 -adrenodegradation in the heart is compartmentalized and medi-ceptor-mediated endothelium-dependent relaxation that ated by different mechanisms than in intravascular spaces is mediated by NO occurs in the coronary but not in the (109) . It has been suggested that the regulation of this femoral arteries in CF (341) . Nitric oxide can be generated enzyme is different depending on the cellular source by three different isoforms of NO synthase (NOS): brain (207) . Pure volume overload is apparently a less potent NOS, endothelial constitutive NOS (ecNOS), and inducactivator of the cardiac RAS. Forty days after an aorta-ible NOS (iNOS). The iNOS mRNA and protein are not caval fistula in rats, the only transcript that is increased present in the normal human heart, but they are coexsignificantly is the ACE, whereas those of renin, angiotenpressed with ANF in the myocardium of patients with sin, and AT 1a and AT 1b were unmodified (217). During CF, both mild and severe CF, independent of the cause, which the activity of ACE is enhanced (434) . Nevertheless, the raises the possibility that autocrine and paracrine actions relative importance of ACE and angiotensin II-forming of iNOS may be of physiopathological importance (193) . chymase in humans is still uncertain, since in vitro assays may underestimate the functional importance of ACE in 6. Catecholamines intracardiac angiotensin II formation (110) .
Both plasma and urinary catecholamines increase in 3. Aldosterone proportion to the severity of CF as a consequence of the Aldosterone is mainly secreted by the adrenal cortex, hemodynamic deficit (142, 358). Norepinephrine stores but there is now evidence that aldosterone can also be are depleted in every kind of decompensated cardiac hysynthesized and regulated in the myocardium (423) . It is pertrophy as initially shown by Chidsey et al. (83). Such as yet not known if the myocardial aldosterone system is a depletion is said to be ''paradoxical'' (58) because it is modified during CR.
accompanied by an increased cardiac interstitial level of 4. Endothelin norepinephrine. The paradox may be due to a marked abnormality in neuronal norepinephrine uptake in CF (58, Endothelin-1 is a potent vasoconstrictor and mitogenic peptide whose plasma level is elevated in CF. Selec-381). Analysis of the left unloaded ventricle compared with the right ventricle in cases of primary pulmonary made by Corda et al. (96), who demonstrated in the pericardial fluid (which is an ultrafiltrate of the plasma) colhypertension in humans has demonstrated that despite the widespread activation of hormonal mechanisms that lected from patients undergoing cardiac surgery high concentrations (3-fold higher than the serum) of fibroblast accompanies the clinical syndrome of CF, such a depletion is under local rather than systemic control (58) .
growth factor-2. The pericardial concentration of growth factor is proportional to the LV mass, suggesting a myoComparable results were obtained in models of CCH in which cardiac hypertrophy was obtained acutely (137) . cardial autocrine production of growth factor at the origin of cardiac hypertrophy. In such models, myocardial catecholamines were depleted, and this was associated with a reduction in the activity of tyrosine hydroxylase, the rate-limiting enzyme I. Cytoskeleton in the synthetic pathway for catecholamines, and with a defect in the reuptake mechanism. Compensated cardiac hypertrophy obtained using a progressive procedure reThere are many lines of evidence which suggest that there is an early and rapid reorganization of the microtuvealed essentially different results. In such models, the ventricular contents of norepinephrine exhibited progres-bular network and an activation of the expression of genes encoding several cytoskeletal proteins. The first suggessive and sustained increases; in addition, transient enhancement of parasympathetic markers was observed in tion that the microtubules may be involved in the cellular rearrangement at the onset of cardiac hypertrophy was both progressive and acutely induced hypertrophy (257).
made by Samuel and co-workers (393, 394) who showed a transient increase in the microtubular network of 7. Bradykinin, prostaglandin E 2 , and cytokines cardiocytes 2-4 days after aortic stenosis. It was suggested that the microtubules may play the role of a guideBradykinin and prostaglandin E 2 are well-known vasodilator components that have been identified in myocar-line in the phenotypic modifications affecting these cells.
b-Actin is also a cytoskeletal protein that plays an imdial effluent. During myocardial ischemia, cardiac production of both components increases (27, 185) .
portant role in the arrangement of microfilaments during myoblast growth. Western blot analysis revealed a similar Tumor necrosis factor-a (TNF-a) is a proinflammatory cytokine that has a cytolytic effect and produces and early transient increase in b-actin in two models of cardiac hypertrophy, i.e., after transmyocardial direct-curnegative inotropic effects by binding to TNF receptors types 1 and 2. The TNF-a mRNA and protein are present rent shock or mitral regurgitation (70) .
Permanent changes in the microtubules were rein the heart, and their level increases in CF. The two TNF receptors subtypes are present both in the heart and ported more recently. Both the microtubular network and tubulin concentration were increased in overloaded cat plasma. Cardiac receptors are downregulated in dilated and ischemic cardiomyopathy; in contrast, soluble recep-ventricles 2 and 6 wk as well as 6 mo after pulmonary arterial stenosis. In contrast, volume overload showed no tors of the plasma increase (136, 261, 467) . The plasma level of both TNF-a and interleukin-6 is normal in patients changes. This has been associated with a pronounced contractile deficit. Colchicine exposure or exposure to a temwith compensated hypertrophy and enhanced in advanced congestive CF (ejection fraction õ16%) (10, 136, perature of 0ЊC depolymerizes the microtubular network, and in parallel normalizes the contractile dysfunction. In 261, 284, 331, 467). In such patients, the elevated plasma TNF-a is not directly related to the degree of cachexia as contrast, in control cells, a 2-h exposure to taxol, known to induce the polymerization process and to inhibit deposuggested (10), since high circulating TNF-a was also found in noncachectic patients and had no real prognostic lymerization, mimics the effects of a stress load and depresses the contractile function. It has been proposed that significance (136, 302). Cardiac cachexia is more likely to be the result of the overall neurohormonal activation than the microtubule network of the cytoskeleton imposes a resistive intracellular load on sarcomere shortening and, from one specific factor (10). Overexpression of TNF-a in the heart using transgenic technology leads to severe when in excess, impedes sarcomere motion (472).
Tagawa et al. (455) , from the same laboratory, sucmyocarditis and cardiomegaly, strongly suggesting that such a cytokine actively participates in end-terminal myo-ceeded in measuring directly the extramyofibrillar cell stiffness and viscosity using magnetic twisting cytometry cardial deterioration (241).
An increasing body of evidence supports the exis-on isolated cardiocytes whose cell surface integrin receptors have been decorated with a synthetic peptide coated tence of paracrine and autocrine growth pathways in the myocardium. However, it is impossible to decide whether with ferromagnetic beads. These authors showed that the increased amount and polymerization of tubulin in right such an activation has a functional significance. Circulating growth factors have been proposed as a mediator in ventricular hypertrophy in the cat has major functional consequences in terms of myocyte dysfunction. In rats cardiac hypertrophy (101); nevertheless, the first suggestion of an autocrine myocardial growth factor system was with pressure-overloaded ventricle, the same group had reported a permanent increase in total and polymerized and sudden death; nevertheless, studies on myocardial fibrosis are still too rare when compared with studies on tubulin that parallels the depression in contractile function (214) . Controversial results were also reported by myocytes, and the majority of our information concerning myocardial fibrosis comes from one group (496) . others. In pressure overload, in the guinea pig, neither the level of b-tubulin nor its polymerized state appears to It is common to identify two different types of fibrosis, namely, reparative and reactive fibrosis. Reparative affect LV function (91) . In rats, after aortic stenosis, an increased amount of polymerized microtubules was also fibrosis occurs as a reaction to a loss of myocardial material (due to necrosis or apoptosis, after myocardial ischobserved; nevertheless, for these authors, such an augmentation was a transient phenomena that disappeared emia or senescence), and it is mainly interstitial. In contrast, reactive fibrosis is observed in the absence of cell after 2-3 days (394).
Other cytoskeletal proteins could also play a role in loss as a reaction to inflammation and is primarily perivascular. Reactive fibrosis further extends into the neighmaintaining a certain degree of cardiocyte stiffness. Titin, a giant protein (molecular mass 3 1 10 6 Da), spans the boring interstitial space (422) . During CR, reactive and reparative fibrosis usually coexist. sarcomeric Z line to M line and provides continuity for the production of force (reviewed in Ref. 243) . Titin protein There are converging reports suggesting that collagen mass, and not collagen concentration, increases in parallel expression is enhanced both in experimental decompensated cardiac hypertrophy in guinea pig and in the failing with cardiac hypertrophy and the degree of mechanical overload. However, fibrosis occurs as an additional prohuman heart and may participate in the impairment of contractility (91, 310) . Desmin forms ringlike bands cess and has different origins. Fibrosis is not directly induced by stretch or mechanical overload and does not around myofibrils at the level of the Z line and could serve as a three-dimensional scaffolding. Desmin is increased participate in the adaptational process. both in compensated and decompensated hypertrophy in the guinea pig and in CF in humans. In addition, in hu-A. Normal Cardiac Extracellular Matrix mans, desmin is disorderly arranged and a-actinin localization is modified (91, 401) . Vinculin anchors actin filaments via a-actinin to the sarcolemma and intercalated
The ECM is composed of many different proteins, including collagen, the components of the pericellular madisks and is a part of an attachment system of myofibers to external membrane. The amount of vinculin present in trix (fibronectin and proteoglycans), components of the basement membrane (laminin, collagen type IV), several the cardiocytes is increased in dilated cardiomyopathy (401).
proteases (including collagenases), and growth factors.
The most important component is type I collagen, which The microtubular modifications are load, chamber, and species specific (492) and, for the moment, the func-is also the main component of fibrosis; it is synthesized and secreted mostly by the fibroblasts (but also by the tional role of such a cytoskeleton structure has only been unequivocally demonstrated in feline right pressure over-smooth muscle cells) at an unusually low rate (it has a half-life of Ç100 days) (reviewed in Refs. 131, 367, 496). load. Changes in cytoskeleton components have only been observed using immunolabeling, and, in CF, it is, for the The ECM is a fibrillar network that embeds myofibers and the whole cardiac structure. It is normally subdivided moment, impossible to decide whether the cytoskeleton components became apparent because of the high degree into three components: the epimysium, which runs along epicardium and endocardium, the perimysium, which of cellular disorganization or if they represent a compensatory mechanism, thereby maintaining the cell shape groups myofibers into bundles, and the endomysium, which surrounds individual myocytes and connects them (401).
to capillaries. Under normal conditions, the ECM, and more especially collagen I and the collagenases, is an IV. PHENOTYPIC CHANGES IN THE important biological determinant of cardiac mechanics.
EXTRACELLULAR MATRIX
1) It is a structural component that maintains the alignment of myocytes and vessels and prevents myocyte slippage during contraction. 2) During systole it has an active Fibrosis is an increased collagen concentration (18, 496) . It enhances myocardial stiffness because collagen I functional role as a force transducer that facilitates relengthening. 3) As a passive functional component, it is is a very rigid protein (the tensile strength of collagen is 50-100 MPa and approaches that of steel), generates the main determinant of diastolic stiffness (502) .
More recently, emphasis has been made on other arrhythmias because fibrosis creates myocardial electrical heterogeneity, and hampers systolic ejection by rendering components of the ECM, such as fibronectin and laminin isoforms; integrins; the cell surface receptors, which are the myocardium heterogeneous. Myocardial fibrosis is probably one of the major biological determinant of fatal likely to play a role in transmembrane signaling; mitogenactivated protein (MAP) kinase activation; and cytoskeleissues in CR, including congestive CF, severe arrhythmias, increases, suggesting that the resulting collagen degradaDiabetes tion is the result of a delicate balance between these two components. These modifications provide a molecular basis for infarct expansion and myocyte slippage. tal rearrangement, suggesting that the ECM is a less inert
The changes in ECM are extremely rapid and start component than has been reported previously (131, 366, by an activation of fibronectin expression, which is rapidly 367). The ECM is essential as a mediator of growth factor followed by collagen mRNA synthesis. Significant and in modulating the cell phenotype during ontogenic amounts of new collagen I and III fibers appear in the development and hypertrophy.
infarcted area on the second to third day after infarction (86, 87, 235) . A definitively constituted scar, formed several weeks after infarction, appears as a three-layered B. Myocardial Fibrosis of Known Origin structure corresponding to the three layers of the muscle that had occupied that space before infarction and is comFibrosis is multifactorial and is caused by myocardial posed of 40% type I, 35% type III, and 25% type V collagen ischemia or hypoxia, senescence (see sect. III), inflamma-with a two-to threefold increase in the concentration tory processes, diabetes, hormones, or vasoactive pep-of hydroxypyridinium cross links (486). The noninfarcted tides (Table 8) (497, 498) . area is equally affected by the fibrotic process, since significant amounts of collagen mRNA and protein have been
Myocardial fibrosis after myocardial infarction
observed after a LV infarction both in the right ventricle and in the noninfarcted area of the left ventricle (86) . The The wound-healing response of the myocardium after mechanism responsible for fibrogenesis in such areas is MI involves both the infarcted area and the noninfarcted still not known and may involve either a direct effect of ventricle. Reparative fibrosis is organized as a scar and is stretch around the scar or diffusion of signals that origisurrounded by reactive fibrosis and compensatory myonate in the ischemic area through the interstitial space cyte hypertrophy (496) ( Table 9) . (496) . This has also been suggested by data from Michel Tissue injury is initially associated with inflammatory et al. (298) who have been able to prevent fibrosis in the cells, mainly macrophages, which produce transforming noninfarcted area by administering CEI 1 wk after the growth factor-b1 (TGF-b1). One of the properties of TGFcoronary ligation. b1 is to transform interstitial fibroblasts into myofibroblasts that are readily detectable 4 days after injury. Myofibroblasts are identifiable because they express 2. Vasoactive peptides and hormone-induced smooth a-actin and contain ACE, high densities of angiomyocardial fibrosis tensin II receptors, and various forms of collagenases (matrix metalloproteinases; MMP) and tissue inhibitors of A) VASOACTIVE PEPTIDES. Angiotensin II is fibrogenic, but the angiotensin II-induced fibrosis is much more com-MMP (TIMP). Transforming growth factor-b1 and angio- http://physrev.physiology.org/ Downloaded from plicated than previously expected because angiotensin II necrosis (187), hypertension, and cardiac hypertrophy are not required for cardiac fibrosis in response to aldosteacts both as a growth factor and a potent vasoconstrictor. Angiotensin receptors have been identified both on rone plus salt (519). 4) Unpublished data from our laboratory have revealed an upregulation of the angiotensin II cardiocytes and fibroblasts. The fibrogenic effect of angiotensin II involves several mechanisms, namely, cell death receptors during aldosterone infusion and have shown that losartan is as efficient as spironolactone in preventing due to the vasoconstricting effect of the peptide responsible for ischemia, a direct trophic effect on the myocytes, fibrosis, suggesting that the RAS may, at least in part, play a role in aldosterone-induced fibrosis. and a proliferative effect on the fibroblasts (through the activation of TGF-b).
Clinical investigations have reinforced this concept. 1) Ventricular and systemic organ fibrosis has been found Chronic administration of angiotensin II to normal rats for 2 wk causes arterial hypertension leading to LV in autopsy-confirmed adrenal adenoma (68) . 2) Aldosterone blockade in patients with mild CF reduces plasma hypertrophy and induces myocyte loss with microscopic scars that appear not only in the overloaded LV but also levels of procollagen type III NH 2 -terminal amino peptide, a marker of vascular collagen turnover (287). in the nonhypertrophied right ventricle (53), in the two atria, and around both the aorta and pulmonary artery Administration of DOCA to rats is very commonly used as a model of arterial hypertension and LV hypertro-(369, 437). Nevertheless, perfusion with nonhypertensive doses of the peptide also generates fibrosis; fibrosis is phy that is accompanied by extensive perivascular ventricular fibrosis (64, 187, 416). Chronic androgen treatdelayed and is not associated with preceding necrosis but implicates coronary vascular hyperpermeability as dem-ment is also associated with fibrous tissue deposits (428) . C) CATECHOLAMINES. Daily injection of isoprenaline in onstrated using an antibody against plasma fibronectin (369) . Finally, there is evidence based on experiments rats for 10 days generates subendocardial myocyte death and stable reparative fibrosis without perivascular fibrosis performed on isolated fibroblasts which suggests that angiotensin II can directly activate collagen synthesis (54) . in the noninvolved areas (422) . Subendocardial fibrillar collagen encircles endocardial muscle fibers that atrophy, Angiotensin II and endothelin-1 may act synergistically to create fibrosis. Endothelin-1 increases both colla-and this leads to reduced active tension. Such a process can explain how fibrosis itself hampers contractile force gen synthesis and cardiac fibroblast proliferation and reduces collagenolytic activity (165).
(219). B) STEROID HORMONES. Aldosterone secretion is an end product of RAS; nevertheless, plasma aldosterone is also 3. Diabetes regulated by several factors other than RAS. Aldosterone Non-insulin-dependent diabetes is associated with ininfusion can induce fibrosis in the absence of any activa-terstitial ventricular fibrosis, resulting from an increased tion of the RAS. Chronic administration of aldosterone to type III collagen (419) . normal rats to uninephrectomized rats maintained on a high-salt diet for 6 wk also led to arterial hypertension and LV hypertrophy. Myocyte loss and fibrosis appear in C. Cardiac Overload Without Fibrosis the two ventricles, atria (53, 375-377, 518), and around the large vessels (437), suggesting a diffuse process that Fibrosis is not inevitably linked to mechanical overload, and there are several experimental and clinical modis not linked to mechanical overload.
The aldosterone-induced fibrosis is both perivascular els of mechanically overloaded hearts with unchanged myocardial stiffness and collagen content (Table 9 ). This and interstitial and is accompanied by necrosis. It is likely to be regulated pretranslationally (376) and to have multi-list is informative and helps improve our understanding of the physiopathology of cardiac fibrosis. ple origins. 1) There are aldosterone receptors in the human myocardium (260) , and a direct effect of the hormone Chronic volume overload due to anemia (23, 395), arteriovenous fistula (301, 500), exercise training, atrial on isolated fibroblasts has been proposed (54); nevertheless, this finding has been contradicted (145, 238) . In addi-septal defect (279), or aortic insufficiency (12) is not accompanied by ventricular fibrosis. There are qualitative tion, the fact that during a continuous infusion of aldosterone in the rat the appearance of fibrosis is delayed (and changes in collagen cross-linking in at least one of these conditions, aortic incompetence (210) . Both the subendostarts 15 days after the beginning of infusion) also argues against a direct effect of the steroid (377) . 2) Fibrosis is cardial myocardial collagen content and the degree of collagen cross-linking were reduced with the developnot caused by a reduced collagenase activity, and in situ zymography has revealed an enhanced collagenase 2 ac-ment of tachycardia-induced dilated cardiomyopathy. In contrast, in the same model with a 4-wk recovery period, tivity in the media of coronary vessels, suggesting that the modification of collagenase reflects vascular remodel-both the collagen concentration and cross-linking increased with a significant enhancement of the interconing and is unrelated to myocardial fibrosis (375 
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There are also models of pressure overload hypertro-volume fraction with interstitial and perivascular fibrosis and microscopic scarring in hypertensive cardiopathy (rephy without ventricular fibrosis. Clinical studies have suggested that an increased diastolic stiffness is associated viewed in Refs. 403, 497). The increased percentage of fibrotic tissue is proportional both to the ventricular mass with aortic stenosis in no more than half of the cases (350) . Infrarenal aortic banding increases arterial pressure and ejection fraction until the threshold value of 250 g is reached. Above this value, the cardiac mass is no longer and LV weight to levels comparable to the most commonly used models of renal hypertension. Infrarenal aortic ste-correlated with ventricular fibrosis, and the percentage of fibrosis reaches a plateau at Ç30% (162). Clinical quantinosis did not activate the glomerula and did not result in an elevation of either circulating angiotensin II or aldoste-fication of ventricular fibrosis has now been made possible by serum procollagen peptide measurements. The serone, suggesting that these two hormones are responsible for ventricular fibrosis in renovascular hypertension or rum concentration of two procollagen peptides, procollagen type II amino terminal peptide and procollagen type models with suprarenal aortic stenosis (53).
I COOH-terminal peptide, is directly correlated with ventricular fibrosis during arterial hypertension (112, 287).
D. Pressure Overload Hypertrophy
The origin of fibrosis is still a highly controversial issue. 1) There is no doubt that in conditions such as renovascular hypertension the high levels of plasma horIn this condition, fibrosis has to be clearly distinguished from the increased collagen content that occurs mones and vasoactive peptides can generate fibrosis (see sect. IVB ). Nevertheless, there are models such as SHR in response to mechanical overload and participates in the adaptational process. Pressure overload is frequently with normal plasma angiotensin II or aldosterone and fibrosis. 2) As discussed in section VC, the local production associated with fibrosis; nevertheless, as explained above, there are models of pressure overload with normal colla-of vasoactive peptides is likely to be another candidate.
3) The myocardial inflammatory cell density increases in gen concentration, and it has been proposed that ventricular fibrosis that is observed in this condition is caused two different models of experimental hypertension, SHR and renovascular hypertension, suggesting that such a celby associated factors linked to arterial hypertension like ischemia, senescence, or diabetes, and plasma hormones lular proliferation is directly linked to mechanical stretch.
In both models, the inflammatory cells, including macroor peptides (498) . Renovascular hypertension, primary or secondary hyperaldosteronism, and CF are indeed clinical phages, T helpers, cytotoxic lymphocytes, and MHC class II-expressing cells (Ia/ cells), are colocalized with fibroconditions that are associated with increased plasma levels of angiotensin II, aldosterone, and catecholamines blasts producing type I collagen, and it has been suggested that such infiltrates may cause fibrogenesis (202, 327, 328). (142). In contrast, clinical trials and experimental pharmacology have demonstrated a reduction in myocardial fi-Hence, it cannot be excluded that myocardial stretch and the presence of periarterial fibrosis in the nonoverloaded brosis when therapy was targeted to one of the corresponding receptors or to the secretion of angiotensin II right ventricle could also be attributed to the intracoronary pressure overload as suggested by Michel and co-(reviewed in Refs. 89, 90, 159, 326, 432) .
In vitro, on an isolated working guinea pig heart, pres-workers (326, 327). 4) A last hypothesis is that fibrosis could result from ischemia as a consequence of the reducsure overload activates myosin synthesis within 3 h; nevertheless, during such a lapse of time, collagen synthesis tion of coronary reserve. This hypothesis is supported by the findings of myocardial microscars in most of the modremains unchanged (406). In vivo, collagen mRNA concentration and the fractional turnover rate of collagen both els (326, 422) . increase rapidly following the imposition of pressure overload (41, 484) and nonmuscle cells proliferate, and it has E. Other Components of Fibrosis been suggested that these modifications are consequences of both an activation of collagen synthesis and proliferation of fibroblasts (41, 319, 429) .
Recent investigations using mRNA and protein quantitation on isolated muscle and nonmuscle cells and autoPerinephritis in primates as well as renovascular hypertension or aortic stenosis in rats all result in reactive radiographic detection have revealed unusually large accumulations of ACE at sites of pathological fibrosis (74, fibrosis. Unilateral renal ischemia, for example, rapidly gives rise to progressive perivascular fibrosis throughout 204, 373, 438; reviewed in Ref. 496) . Such an anatomic coincidence was found in various models including MI, the myocardium and from which fibrillar collagen extended into the extracellular space creating interstitial isoproterenol-induced cardiac hypertrophy, renovascular hypertension, and angiotensin II-or aldosterone-induced fibrosis and subendocardial microscopic scarring (75, 218, 326, 327, 422 (199) . Angiotensin II receptor subtype 1 is also asso-ferent from that obtained with collagen I or III, was observed after aortic banding with renal ischemia (75) . An ciated with myocardial fibrosis after MI (373) . Bradykinin receptor density is equally augmented in perivascular fi-increased galactosyltransferase expression was found in failing hearts, the enzyme is involved in glycoprotein synbrosis and microscarrings in the angiotensin II-and aldosterone-induced models (496) . Finally, unpublished data thesis, and this activation may be consistent with the ECM upregulation reported in this model (47). from our laboratory have demonstrated an increased expression of angiotensin II receptors, with a differential regulation of the two main subtypes, ATR1 and ATR2, V. CELL DEATH both in the aldosterone-induced cardiac fibrosis and in the fibrotic senescence rat heart. Such an increase in the Cell death is an important determinant of CR because number of angiotensin II receptors is likely to occur both it causes a loss of contractile tissue, compensatory hyperon the nonmuscular cells, where it reflects the high recep-trophy of myocardial cells, and reparative fibrosis. Cell tor density in fibroblasts, and in myocytes, as a result of death may in fact be the only cause of fibrosis. A reduction volume overload.
of contractile material is a prominent feature in human CF whatever the origin and is accompanied by compensatory hypertrophy of myocytes and interstitial fibrosis (344, 401, F. Other Components of the Extracellular Matrix 402). Cell death can occur either by necrosis or apoptosis.
Pericellular matrix
The latter qualifies a genetically programmed cell death It has now been clearly established that fibronectin due to the activation of an endogenous endonuclease. The accumulation precedes collagen accumulation during fi-resulting DNA fragmentation produces a characteristic brillogenesis (reviewed in Ref. 131) in various models re-''ladder'' when size-fractionated by electrophoresis. lated to CR, including thoracic aortic stenosis (94, 484), Apoptosis is associated with the expression of a number aortic stenosis (392), SHR (273) , MI (235) , angiotensin II-of regulatory genes commonly used as markers of induced hypertension (368, 369), mineralocorticoid-in-apoptosis, including bcl-2, an antiapoptotic protooncoduced hypertension (273) , and isoprenaline-induced car-gene, Fas, a proapoptotic gene, as well as others. In condiac hypertrophy (368). Fibronectin mRNA is in fact rap-trast to necrosis, apoptosis is commonly viewed by its idly and transiently expressed in the perivascular area, requirement for de novo gene expression. Consequently, even during pressure overload (94, 235, 484) , and precedes apoptosis is sensitive to mRNA or protein synthesis inhibithat of collagen I and III transcripts.
tors. There are compelling evidences in support of reacFibronectin is encoded by a single gene, and polymor-tive oxygen species (including superoxide and hydrogen phism is the result of alternative splicing of this gene. peroxide)-induced apoptosis occurring not only during Two different isoforms, FN-EIIIA/ and FN-EIIIB/, are hypoxia or ischemia (474) but also after overstretch (78) coexpressed during cardiac ontogenesis. Detailed studies and NO-induced apoptosis (356). Apoptosis plays an imof these isoforms have failed to show any specific expres-portant role during development (220) . During cardiac sion of a single fetal pattern (130, 274) . The FN-IIIA/ is development, the rate of DNA degradation diminished and the unique isoform expressed in most of the models of is inversely related to bcl-2 levels (228). hypertensive cardiopathy (130, 484; reviewed in Ref. 131 ).
This topic is becoming very popular in cardiology Studies of aging SHR have revealed a parallel expression (36) because apoptosis is rather easy to identify by the of FN-EIIIA/, TGF-b1, and collagen during the transition detection of DNA fragments in size multiples of 200 bp between nonfailing and failing cardiac hypertrophy (47). and by the expression of marker genes and preserved
To summarize, fibronectin is probably one of the cytoplasmic structures, although these three (or at least components of the biological cascade triggered by isch-the first two) criteria have rarely been met. Necrosis is emia, vasoactive peptides, or catecholamines and that characterized by severe membrane alterations and is prewould include the sequential expression of TGF-b1, fi-ceded by a period of time during which the diseased cells bronectin, and then collagen I.
become permeable to immunoglobulins such as radioactive monoclonal antibodies raised against myosin. Unin-2. Basement membrane jured cells remain unlabeled.
Laminin and type IV collagen contribute to the ECM assembly during healing after MI. A detailed immunohisto-A. Ischemia chemical study has shown that the distribution of the two components gradually progressed from the peripheral Surprisingly, the main cause of cellular loss during myocardial ischemia is not necrosis but apoptosis. In vitro zone to reach the central infarcted area by the second week after coronary ligation (312) . A similar pattern, dif-studies using cultured neonatal cardiocytes exposed to Kajstura et al. (226) in the sis is observed within the first 3 days of angiotensin II rat model of MI and led to the conclusion that during the infusion before the elevation of plasma norepinephrine first 6 h after coronary occlusion programmed cell death levels and is prevented by both losartan and propranolol, is the major form of myocardial damage (representing suggesting that it is caused by angiotensin II-induced re-ú90% of the dying cells). Necrotic cells prevailed at later lease of neural catecholamines within the heart (195) . times (2 days), and a similar small number of apoptotic Angiotensin II directly antagonized NO donor-induced and necrotic cells were observed on the seventh day. Studapoptosis (356). ies of myocardial samples from patients who died from
Pioneer studies have demonstrated that subcutaneacute MI showed typical apoptotic myocytes mainly in ous administration of isoproterenol produces graded myothe border zone of the infarcted myocardium and concardial necrosis and reduction in cardiac performance (refirmed the predominance of apoptotic compared with neviewed in Ref. Changes in myocardial function precede the end It has subsequently been suggested that apoptosis is a stage of CF; failure obviously indicates the limits and imregulatory mechanism that participates in the initiation of perfections of the adaptational process and is dependent the hypertrophic process. Apoptosis, as a consequence of on both myocardial and peripheral factors. Recent adstretch (78) , may in fact result from the overall systemic vances in the biology of cardiac hypertrophy and failure arterial overload as has been demonstrated in nearly every have allowed one to separate three groups of trophic facorgan, including the heart, kidney, and brain, in two exper-tors that act independently, namely, the adaptational proimental models of arterial hypertension, the SHR model, cess to the new hemodynamic conditions, factors linked and the genetically hypertensive mice (175) .
to etiology, and neuroendocrine reactions. Each of these A few reports have recently shown an increased num-factors plays a role in the genesis of the abnormalities in ber of apoptotic cardiocytes in failing hearts. It is for the cardiac function, i.e., systolic and diastolic dysfunction, moment impossible to decide whether apoptosis is the and arrhythmias. The mechanisms leading to arrhythmias cause or a consequence of CF. Fragmentation and lad-are much more complex than those responsible for sysdering of DNA have been demonstrated during cardiac tolic and diastolic function. transplantation in all patients with dilated cardiomyopathy. In ischemic cardiopathy, apoptotic cells were not ob-A. Systolic Ejection and Active Relaxation served in the nonischemic area, but only in the infarcted zone (320). In the transition model of aging SHR, apoptotic cells in association with increased levels of WAF-1 mRNA Clinically detectable alterations in systolic ejection and active relaxation occur later in vivo than in vitro and were nearly fivefold more abundant in the failing than in the nonfailing hearts, suggesting that apoptosis might be can be observed on a papillary muscle or by biochemical or molecular biological methods (7, 246, 247 ations in systolic function are initially adaptational, but dium was occupied by collagen. 2) Investigations carried out on the isoproterenol model in rats have revealed a they also simultaneously indicate the beginning of failure. The cardiac output can be maintained by several compen-dose-dependent increase in ventricular end-diastolic pressure, volume indexes, diastolic stiffness, and global wall satory mechanisms including Starling's law, peripheral adaptation, and the sympathetic drive.
stress that is associated with compensatory hypertrophy and reparative fibrosis (462) . 3) Lathyrogen-B aminoproIn rat ventricles, the shift in ventricular isomyosins is correlated with the shortening velocity (412); neverthe-prionitrile, a component which hampers collagen synthesis, prevents changes in diastolic stiffness induced by aorless, there is also evidence that the calcium movements are altered in parallel (7, 481) . In the human ventricle, tic banding (39). 4) Perfusion of isolated hearts with bacterial collagenase for 60 min resulted in low collagen there are no significant isomyosin shifts (49, 245) , and the adaptation is more likely to be due to a slowing of the content, ventricular dilatation, and changes in chamber stiffness (289). Diastolic dysfunction reduces the passive calcium transient, which is itself determined by changes in the expression of genes encoding membrane proteins. ventricular filling. Such a reduction is compensated by an enhanced atrial contribution (146) . Other sarcomeric mechanisms have been proposed (205, 206, 509) .
When passive compliance is altered by fibrosis, atrial C. Arrhythmias and Changes in Heart Rate contraction plays an important role in compensating for the deficiency in ventricular filling as shown by echoSudden death, presumably related to severe arrhythDoppler. Atrial contractility is mainly under the control mias, accounts for at least 50% of deaths among patients of the contractile proteins and depends on the myosin with CF. Interestingly, the high incidence of arrhythmias ATPase activity and the type of isomyosin present in the in CF is unrelated to ischemic heart diseases. In addition, atria. During hemodynamic overload, the composition of epidemiological surveys and animal experiments have the atria changes from 100% V1 to 100% V3 isoform (292, shown a high incidence of benign arrhythmias in CCH 470). From a thermodynamic point of view, such an isomy-(19, 80, 251, 447). Several attempts have been made to osin shift can be considered as a compensatory mecha-predict severe arrhythmias by using various indexes innism that allows the atria to maintain an increased output cluding heart rate, heart rate variability, and Q-T interval. at a low energy cost.
The biological substrate for arrhythmogenicity in CR Fibrosis is also one of the determinants of systolic is a complex issue (19, 447). Fibrosis and changes in the function that is impaired by myocardial heterogeneity, membrane protein composition are both essential during and also by the encircling of myofibers that imposes a the compensated phase. Additional factors including physical restraint on muscle distension, as shown in the plasma catecholamines and ventricular dilatation are inrat in a model which associates both reparative and reac-volved during CF. tive fibrosis (218).
Compensated hypertrophy
B. Diastolic Dysfunction
Attempts to separate fibrosis from the other biological determinants of arrhythmias in CCH have been made by Pahor et al. (345) and, in our group, by Chevalier et Left ventricular diastolic dysfunction in cardiac hypertrophy results from two different factors, namely, the al. (80) . The degree of cardiac hypertrophy and the percentage of ventricular fibrosis are indeed linked to one alterations in active relaxation which in turn depends on the biological process of adaptation and the changes in another; nevertheless, correspondence analysis has shown that fibrosis and cardiac hypertrophy are independiastolic compliance which are direct consequences of chamber diameter and collagen concentration (62). Ven-dent arrhythmogenic factors.
Three basic mechanisms are involved in the genesis tricular chamber compliance (the pressure-volume curve) depends on the ventricular diameter. Ventricular tissue of arrhythmias: reentry, abnormal automaticity, and triggered activity. 1) Reentry is directly linked to fibrosis and compliance (the stress-strain curve) is determined by collagen concentration and the degree of fibrosis (146) .
also to the changes in connexin isoforms. Fibrosis can create the alternative pathway and conduction block and Several experimental designs have investigated the importance of collagen content and distribution on myo-slows the conduction. 2) Fibrosis is one component of the arrhythmogenic substrate responsible for the genesis cardial mechanics. 1) In rats, using different models that provide a wide range of collagen concentrations and dis-and maintenance of triggered ventricular arrhythmias after MI (52); conversely, arrhythmias are rare in aortic tributions, Jalil et al. (218) have demonstrated that passive stiffness, measured in vitro on Langendorff-perfused insufficiency (396), which is not associated with myocardial fibrosis, as explained above. In the senescent human hearts, parallels collagen volume fraction. Passive stiffness rose disproportionately when ú15% of the myocar-heart, an alternative explanation, called the zig-zag mecha-nism, has been proposed (431). The same mechanism has the second phase, between 10 and 30 min of ischemia, arrhythmias are mainly due to damage in the cell-to-cell been proposed in patients with hypertrophic (399) or dilated (8) cardiomyopathies. Patients undergoing cardiac coupling which alters the conduction and increases the propensity for reentry (reviewed in Ref. 221 ). The high transplantation were examined with a similar technique, and the amount of fibrosis was again found to be corre-incidence of ischemia-induced arrhythmias in CF has several explanations (see section VIC1) including changes in lated with severely abnormal propagation (8) . 3) Nonreentrant mechanisms also arise in the subendocardium (354). connexins, calcium-regulating proteins, and fibrosis (483).
Finally, CF also is associated with pronounced modiIschemia due to the arteriolar wall thickening (414) may be one of the nonreentrant mechanisms capable of initiat-fications of the autonomous nervous system, which favors arrhythmias. Heart rate variability, which is the best noning arrhythmias. The new cardiocyte phenotype favors both automaticity and triggered activity.
invasive indicator of the autonomous nervous system activity, is both reduced and less chaotic (359) with both abnormalities in the myocardial structure (i.e., showed that the hypertrophied rat heart has a greater propensity to develop both delayed and early afterdepo-CR) and clinical symptoms due to fluid retention (i.e., tachypnea, edema, and congestion of liver). The severity larizations. Such a scheme requires a real substrate with regard to the changes in genetic expression of the mem-of the disease is commonly appreciated using the NYHA classification, which is entirely based on functional sympbrane proteins, including therapy with agents able to modify [Ca 2/ ] i such as digitalis and catecholamines, hypokalie-toms. Cardiac remodeling is most commonly caused by MI and/or arterial hypertension, i.e., by LV overload; conmia, stress, ischemia, and anoxia.
2) The other mechanism involves the expression of ionic channels, such as I f or sequently, the most commonly observed early symptom of CF is dyspnea initially during exercising and then at I CaT which normally initiate slow depolarization in the sinus node (73) . Finally, abnormal activity can be trig-rest. Such a clinical symptom indicates that the ejection fraction is altered and that the end-diastolic pressure gered by impulse generation due to early or delayed afterdepolarization. Early afterdepolarization is facilitated by starts to increase.
The functional nature of such a definition renders the increased duration of action potentials, a well-known finding.
the experimental approach of the transition difficult. It is indeed difficult to quantitate tachypnea in a rat. Schematically, the heart can fail for three reasons. 1) Failure may 2. Cardiac failure and postmyocardial infarction indicate the limits of the above-defined adaptational process. Every phenotypic modification has a limit, e.g., the Cardiac failure and MI are known arrhythmogenic substrates associated with several predisposing factors, beneficial effects, in terms of myocardial economy, of the isomyosin shift are maximum when the fast myosin (V1) including metabolic and neurohumoral disorders, mechanical stretch due to acute ventricular dilation, isch-has been completely replaced by the slow isoform (V3).
2) Fibrosis whether it is caused by the trophic effects of emia, myocardial hypertrophy, and fibrosis. ''Contractionexcitation feedback'' has been defined as the changes in vasoactive peptides, senescence, or ischemia can play a crucial role, even if the adaptational process does not the mechanical state that precede or alter the transmembrane potential (242). It is a sort of potpourri comprising reach its limits. 3) Finally, failure can be caused by a loss of muscle due to necrosis or apoptosis. In fact, the three the direct effects of stretch on action potential duration, increased dispersion of ventricular repolarization, and reasons are frequently associated although to various degrees; several months after MI, the decrease in ejection electrical instability, which are linked to the state of decompensation (143, 242, 362) .
fraction is caused by a combination of fibrosis, loss of substance, and inability of the adaptational process to During acute myocardial ischemia, the arrhythmia appears in two distinct phases. During the first phase, ar-compensate.
There are no specific biological markers for CF. Carrhythmias are reentry arrhythmias that are mainly caused by extracellular potassium accumulation; later on, during diac failure depends on a myocardial deficit, but the hemo-dynamic consequences can be entirely masked by the gene expression of TGF-b1 and that failure occurs through this pathway when fibrosis reaches a certain compensatory effects of peripheral factors. In addition, in terms of cellular biology, failure depends on the whole level (47). Another biological marker of the transient that has been proposed is the disappearance of the senactivity of the cells and tissue and is not the consequence of the deficit of one particular molecule.
sitivity to b-agonists (37) . The markers can differ from one model to another; in guinea pig after aortic banding, The transition from compensated to decompensated cardiac hypertrophy has in fact been rather rarely the Ca 2/ -ATPase of SR remains unchanged in compensated hypertrophy and is only modified in CF (232). studied. There are for the moment only few experimental models that allow such an analysis. 1 ) Spontaneously hypertensive rats develop impaired myocardial VII. CARDIAC REMODELING DUE function and biventricular congestive CF at the age of TO SENESCENCE 18 mo after a long period of CCH due to arterial hypertension. Aging SHR provide a reproducible although Studies on cardiovascular senescence are far from rather expensive model, and one of the determinants of being academic, since epidemiological studies have CF is senescence. Fifty-seven percent of a group of 30 shown that CR is the main cause of mortality in people 18-to 24-mo-old male SHR developed clinical evidence over 65 yr of age. Therefore, it is of major importance to of decompensation, and only 13% survived to 24 mo. assess the limits of normality during aging. The clinical Pathological assessment of CF shows left and right ven-problem is far from being simple because the fundamental tricular hypertrophy that is associated with liver hyper-biological process of senescence is intimately associated trophy and pleuropericardial effusions, and studies on with an increased incidence of arterial hypertension, athmyocardial function have revealed impaired systolic erosclerosis, and modifications in physical activity and function, increased end-diastolic volume, and diastolic nutritional status, which all may seriously modify the myostiffness (38, 468) . 2) Dahl salt-sensitive rats fed with a cardial structure. high-salt diet after the age of 6 wk developed concentric This subject has already been extensively reviewed LV hypertrophy at 11 wk and CF with ventricular dilata- (32, 138, 140, 244) . Therefore, we only summarize the main tion and increased plasma concentration in norepineph-differences and similarities that exist between the normal rine at 15 -20 wk. In failing hearts, isometric contrac-senescent heart and the overloaded heart (Table 10) . Cartions of the papillary muscle have shown a reduced diac overload has frequently been considered as a premacontractility, and histological quantification has re-turely aged heart, which is obviously incorrect (32) . From vealed modest subendocardial and perivascular ventric-a biological point of view, the modifications of the senesular fibrosis probably because of the age of the animals cent heart result from three different factors, including (213) . 3) Stenosis of the descending aorta in guinea the general process of senescence, the senescence of the pigs results in some cases in congestive CF with an endocrine system, and above all the senescence of the increased lung-to-body weight ratio. Animals with nor-vessels (the increased characteristic aortic impedance mal lungs had unchanged myocardial performance which creates a LV overload). (232) , which is different from what is observed in the nonfailing SHR (37). 4 ) Myocardial infarction in young rats gives rise to diastolic and systolic congestive failure A. The Senescent Heart: an Overloaded Heart and pronounced alterations of ventricular compliance (299, 352) . The model is widely used but is not so easy
The senescent heart, in the absence of arterial hypertension and coronary insufficiency, is in many respects as a model to study transition because the failing period is rather unpredictable. comparable to LV overload. As such, it contracts more economically (31) , and this is caused by the same phenoSearch for molecular markers of the transition are for the moment only beginning. In the SHR model, mo-typic modifications of contractile and membrane proteins as in the pressure-overloaded heart, including the ventriclecular biology has shown a progressive decline in the amount of the a-MHC isoform and SR Ca 2/ -ATPase and ular isomyosin change in rats, the modifications of the external membrane and sarcoplasmic reticulum proteins, an increase in ANF when compared with control, compensated hypertrophic, and failing hearts. Nevertheless, and the activation of ANF and RAS (199, 200, 240, 458) ( Table 10 ). An interesting finding, made in humans (183), the only real markers of failure, i.e., the only probes which really allow one to distinguish between compen-is that the force-time integral of the individual myosin cross-bridge cycle is correlated with the age of the patient sated and decompensated states, are probes specific for the ECM components, i.e., fibronectin (specially the with nonfailing myocardium, suggesting that, even in humans, aging is also associated with an improvement of EIIIA/ isoform), pro-a 1 (I) and (III) collagen isoforms, and TGF-b1, and it was proposed that mechanical over-contraction economy.
The blunted response of the autonomous nervous load can directly or indirectly activate the fibroblastic suggested that the process is gender specific and does not Autocrine system occur in women (339) . The cause of death includes both
Renin-angiotensin system (199, 200) ischemic necrosis due to the age-related reduction in coroCirculating F or Å f* Myocardial F F nary reserve and apoptosis that is temporally and spatially Angiotensin II receptor F F unrelated to necrosis. Necrosis is the predominant cause Atrial natriuretic factor (199, 473) of cell death; quantification has indeed shown that there Plasma levels F F Left ventricular mRNA F F are Ç1,000 times more necrotic cells than apoptotic cells.
Extracellular matrix (31, 33, 122, 375) Apoptosis during aging is localized into the left ventricle,
Collagen concentration F or Å F* suggesting that it is initiated by mechanical factors (227).
Collagen mRNA
Myocardial fibrosis is also a constant finding in healthy senescent hearts both in rats and humans (11, 31, f, Decreased; F, enhanced; Å, unchanged; /, frequent or abundant; 33, 122, 274, 339) . Cardiac fibrosis in this condition is ///, very frequent; ?, has to be confirmed.
The undiseased senescertainly, at least in part, a reparative process related to cent heart is reviewed in Refs. 32, 138, 140, and 244. References quoted here only concern senescence. References related to overload are in myocyte death and predominates in the subendocardium. during aging is a complex phenomenon. Two different studies have provided converging results and have shown a paradoxically inverse relationship between the protein system to exercising is a well-documented finding (166, 244) and is accompanied by a reduction in the density of and mRNA content of collagen in aging hearts; the lower the mRNA concentration, the higher the protein levels both b-adrenergic and muscarinic receptors. However, the decrease in muscarinic receptor density is greater (33, 122) , which is in contrast to the situation observed with fibronectin (274) . In addition, a 40-45% diminution than that in total b-adrenergic receptors (82, 166, 179, 180) . A similar decrease in the number of muscarinic re-of both collagenase MMP2 and MMP1 has recently been evidenced in 22-to 24-mo-old rats, suggesting that collaceptors has also been reported in the cerebral cortex, striatum, and hippocampus, suggesting that, for unknown gen accumulation is, at least in part, regulated at the level of the degradative pathway, which is in contrast to the reasons, aging has a rather specific and pronounced effect on the muscarinic system (104) . situation observed in the aldosterone model (375) . Aging also modifies the endocrine system and is assoFinally, the modifications in both protein synthesis and degradation and mRNA content that occur during ciated with an increased plasma level of cortisol and low 5 . Biological determinants of cardiac remodeling: a scheme. Initial event is ''mechanical stress,'' which in fact is myocardial infarction (MI) and/or arterial hypertension. In practice, stress is rarely acute and generally progressive. After MI, main stress is stretch around scar. Mechanical stress modifies genetic expression directly or through activation of myocardial autocrine function. RAS, renin-angiotensin system. 1) Adaptational process is basically beneficial and improves muscular economy; nevertheless, and simultaneously, process has also potentially deleterious consequences (i.e., slowing of shortening veloctiy simultaneously allows heart to produce normal active tension and is first step of reduction of cardiac output). 2) Another heterogeneous group of factors is specific for certain etiologies (senescence, ischemia) or due to hemodynamic deficit (and then proportional to severity of cardiac failure). Such factors cause fibrosis and cell death and also may modify phenotype of myocytes due to trophicity of several hormones or peptides (see Table 3 ), have deleterious consequences on myocardial functions, and modify adaptational program. 3) Both processes are simultaneous in clinical conditions. plasma levels of free thyroxine (but 3,3,5-triiodothyro-is independent of changes in the ECM changes. Nevertheless, chronic congestive CF rarely occurs in the absence nine is unchanged), angiotensin I and II, renin activity, and angiotensinogen (199, 200) , which is clearly different of additional factors, namely, fibrosis or cell death. 3) In clinical practice, CR and CF are diseases of aging people from the situation observed in pressure overload. In contrast, during aging, the angiotensinogen and ACE myocar-with MI and/or arterial hypertension. From a biological point of view, cardiocyte modifications, cell death, and dial mRNA levels are both upregulated. This upregulation is restricted to the left ventricle and does not exist in the fibrosis are associated in the failing human heart. More information is needed to appreciate the exact role of cell right ventricle (97, 199) . The specific LV activation of these death. Fibrosis renders the myocardium stiffer and menormally poorly expressed genes suggests that the trigger chanically and electrically heterogeneous, and this plays for activation is a LV mechanical overload. a crucial role in the genesis of arrhythmias and deterioraCardiac failure is mainly a disease of the elderly, and tion of both systolic and diastolic function. For the mothe average age of the patients in most of the clinical trials ment, therefore, fibrosis is the best marker of CF. is Ç70 yr (93, 430). Obviously, most of the patients under Future researches will certainly benefit from the recent CEI have a low plasma level of angiotensin II, and the developments in genome-based methods. Recently, using question is how such a therapy works in the elderly? The one of these methods, the expressed sequence tags (EST), answer is most likely to be found in the various tissue Liew's group in Toronto (209) published the first publicly systems, at least the ones located in the myocardium. available database of human cardiovascular containing To conclude, the senescent heart, even in the absence 43,285 EST; of these, 55% matched to known genes in speof arterial hypertension or coronary insufficiency, is pocific database. Comparisons between different specific cartentially a diseased heart. Myocardial function in the eldiac libraries allowed the identification of 34 genes that derly is still normal because of the various adaptational were overexpressed in cardiac hypertrophy, including mitomechanisms (19). As such, it resembles CCH occurring chondrial genome transcripts, MLC2, brain natriuretic pepbefore NYHA stage I during the course of an arterial hytide, desmin, 70-kDa heat-shock protein, superoxide dismupertension.
tase, ANF, a-tropomyosin, and a-actin. Several unexpected overexpressed genes were also discovered, including ribo-VIII. CONCLUSION somal proteins, TIMP-4, prostaglandin D synthase, strongly suggesting that the methodology holds tremendous potenTo conclude, 1) CR is a rather complex issue and tial for genome-wide research for novel genes involved in results from interactions between mechanical factors that CR. Several other techniques are already available, includcause adaptational modifications of the cardiocyte, and ing DNA microarrays (111), mRNA differential displays numerous etiologic, epidemiological, or neurohormonal (253, 493), or the serial analysis of gene expression (524) , factors that all are capable of modifying the cardiocyte and it is easy to predict that we should soon have informaphenotype can cause cell death and trigger the fibrotic tion concerning the whole pattern of expressed sequences process (Fig. 5). 2) The slowing of the shortening velocity during the various steps of CR instead of disperse informations such as those presently available. is a consequence of the general process of adaptation and overload (see Table 3 ). 
